Alzheimer's disease: A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
14379 |
4. Check minimum number of eventsNone |
14379 |
5. Include endpointsNone |
14379 |
6. Filter based on genotype QC (FinnGen only) |
14379 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G30-G32
- Name in latin
- Morbus Alzheimer
Similar endpoints
↥List of similar endpoints to
Alzheimer disease
based on the number of shared cases.
Similar with more cases:
- Alzheimer disease, excluding more controls
- Degenerative diseases of the nervous system
- Alzheimer disease, including avohilmo
- Other degenerative diseases of the nervous system
- Unspecific neurodegenerative disorder
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 227475 | 144794 | 80971 |
| Only index persons | 189864 | 122913 | 66951 |
| Unadjusted period prevalence (%) | |||
| Whole population | 3.46 | 4.15 | 2.26 |
| Only index persons | 3.83 | 4.52 | 2.56 |
| Median age at first event (years) | |||
| Whole population | 82.31 | 83.07 | 81.01 |
| Only index persons | 82.76 | 83.50 | 81.40 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 14379 | 6758 | 7621 |
| Unadjusted period prevalence (%) | 2.86 | 2.30 | 3.36 |
| Median age at first event (years) | 80.52 | 80.57 | 80.47 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 9844
- Matched controls
- 79845
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A28
ICPC
Limited function/disability NOS
2.9
323.0
3233
11508
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
60.2
323.0
2465
440
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
32.3
323.0
930
257
P20
ICPC
Memory disturbance
6.5
323.0
4288
8495
N06DA04
ATC
galantamine; oral
19.8
323.0
1265
590
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
6.4
323.0
2581
4185
G30.1
ICD-10 Finland
Alzheimer disease with late onset
123.3
323.0
5812
919
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
273.7
323.0
3421
155
N06DA02
ATC
donepezil; oral
43.5
323.0
4692
1637
N06DA03
ATC
rivastigmine; oral, transdermal
30.4
323.0
2810
1037
G30
ICD-10 Finland
Alzheimer disease
64.9
323.0
855
117
F03
ICD-10 Finland
Unspecified dementia
7.9
323.0
1951
2415
F0019, G301
ICD-10 Finland
NA
+∞
323.0
483
*
G30.8
ICD-10 Finland
Other Alzheimer disease
54.4
323.0
1700
305
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
30.5
323.0
1277
388
N06DX01
ATC
memantine; oral
56.7
323.0
5608
1821
P70
ICPC
Dementia
17.4
323.0
1158
606
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
209.0
323.0
490
20
SPAT1053
SPAT
Memory test
3.6
323.0
3770
11844
N05AX08
ATC
risperidone; systemic
10.8
323.0
2669
2648
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
88.4
323.0
4142
651
N05AH04
ATC
quetiapine; oral
4.8
323.0
2140
4378
G30.0
ICD-10 Finland
Alzheimer disease with early onset
442.4
323.0
851
17
F009, G309
ICD-10 Finland
NA
1455.7
319.0
335
*
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
17.5
292.8
498
242
R41.3
ICD-10 Finland
Other amnesia
6.4
285.5
834
1139
SPAT1245
SPAT
Provision of support and information to patient’s family members
4.2
278.1
1191
2507
R53
ICD-10 Finland
Malaise and fatigue
2.5
267.1
2828
11246
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
30.7
261.6
376
103
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.9
238.9
1705
5330
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.1
236.4
3825
18379
SPAT1216
SPAT
Assessment of functional ability
2.3
221.6
2524
10244
N05BA04
ATC
oxazepam; oral
2.2
213.3
2769
11929
F06.7
ICD-10 Finland
Mild cognitive disorder
5.0
208.5
746
1291
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.1
202.4
1306
3780
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
191.2
3794
19321
SPAT1234
SPAT
Support of social functional capacity
3.4
186.3
1031
2657
WYA20
NOMESCO Finland
Home visit
7.5
181.3
466
523
TAB00
NOMESCO Finland
Lumbar puncture
5.7
178.2
565
846
N06AX11
ATC
mirtazapine; oral
2.0
171.5
3018
14520
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
170.5
2553
11503
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
163.1
2006
8265
AA1AD
NOMESCO Finland
CT of head and brain
1.9
158.8
3071
15215
F0009, G300
ICD-10 Finland
NA
+∞
155.9
162
*
F05.1
ICD-10 Finland
Delirium superimposed on dementia
13.0
149.4
285
183
R41.0
ICD-10 Finland
Disorientation, unspecified
3.8
148.8
696
1552
N06AB10
ATC
escitalopram; oral
2.5
147.8
1390
4988
F00.00
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
70.8
146.2
180
21
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.1
141.0
881
2459
SPAT1254
SPAT
Administration of medicine
2.1
136.3
1959
8554
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
135.2
2148
9763
N03AG01
ATC
valproic acid; systemic, rectal
3.8
133.8
628
1402
F0029, G308
ICD-10 Finland
NA
+∞
123.1
128
*
N02BE01
ATC
paracetamol; systemic, rectal
1.8
119.3
7851
54850
A06AD11
ATC
lactulose; oral
1.9
118.3
2248
10841
N05AH03
ATC
olanzapine; systemic
4.3
116.3
480
951
L28
ICPC
Limited function/disability (L)
1.9
114.3
2172
10454
A04
ICPC
Weakness/tiredness general
2.1
111.1
1571
6747
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
108.1
1227
17205
F0014, G301
ICD-10 Finland
NA
917.9
105.7
112
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.9
103.9
720
2139
N05BA06
ATC
lorazepam; systemic, sublingual
2.8
101.2
720
2173
XA800
NOMESCO Finland
Neuropsychological investigation
4.6
96.4
367
670
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
95.0
1695
7910
F00.14
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type
49.6
93.4
121
20
Z75.5
ICD-10 Finland
Holiday relief care
5.7
91.1
285
417
130
Kela drug reimbursment
Malignant tumour
0.3
88.3
206
5285
N05AD01
ATC
haloperidol; systemic
3.1
87.8
523
1398
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
4.7
87.2
322
569
S72.0
ICD-10 Finland
Fracture of neck of femur
2.5
85.1
743
2521
F001, G301
ICD-10 Finland
NA
52.5
85.0
109
17
N06AB04
ATC
citalopram; systemic
1.8
83.9
1859
9283
U04
ICPC
Incontinence urine
2.5
80.5
679
2257
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
4.8
80.4
290
500
F00.1
ICD-10 Finland
Dementia in Alzheimer disease with late onset
63.1
80.2
100
13
F00
ICD-10 Finland
Dementia in Alzheimer disease
15.2
80.0
142
77
N06AX26
ATC
vortioxetine; oral
3.6
79.6
396
923
SPAT1360
SPAT
Extensive global examination
2.2
77.8
918
3609
S01.0
ICD-10 Finland
Open wound of scalp
2.2
74.8
875
3423
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.9
73.8
487
1395
R55
ICD-10 Finland
Syncope and collapse
1.8
72.8
1405
6676
N02AA05
ATC
oxycodone; systemic
1.7
71.1
1806
9343
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.8
71.0
1345
6345
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
70.9
1592
7936
SPAT1301
SPAT
No procedures
1.5
70.2
3188
19117
SPAT1101
SPAT
Orthostatic test
2.3
67.6
719
2687
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.3
65.0
649
2351
F21
ICPC
NA
5.2
62.3
208
330
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
29.3
59.8
86
24
SPAT1246
SPAT
Screening of depression or other psychiatric problem
3.5
57.9
290
680
S06.0
ICD-10 Finland
Concussion
1.9
56.9
919
4078
S70.0
ICD-10 Finland
Contusion of hip
2.5
56.8
486
1623
F05.9
ICD-10 Finland
Delirium, unspecified
3.0
56.1
346
945
I95.1
ICD-10 Finland
Orthostatic hypotension
2.3
55.3
581
2153
SPAT1252
SPAT
Overall medication plan or its review
1.9
54.4
867
3825
SPAT1229
SPAT
Assessment of need for aid
1.8
53.4
1028
4844
SPAT1172
SPAT
Guidance concerning hydration
2.7
53.2
396
1221
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.8
52.5
373
1118
H02AB02
ATC
dexamethasone; systemic
0.4
50.9
221
4367
F0011, G301
ICD-10 Finland
NA
+∞
50.9
53
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
50.7
1304
6701
W19
ICD-10 Finland
Unspecified fall
1.8
50.0
926
4303
G04CA02
ATC
tamsulosin; oral
1.4
48.6
3265
20788
SPAT1304
SPAT
Counselling and guidance related to ageing
1.7
48.3
1076
5298
Z01.9
ICD-10 Finland
Special examination, unspecified
2.2
47.7
525
1988
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
4.0
47.5
206
428
SPAT1251
SPAT
Organisation of medication
2.3
47.4
485
1774
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.8
47.2
975
4691
N05AD03
ATC
melperone; systemic
3.5
47.0
235
551
N02AJ06
ATC
codeine and paracetamol; systemic
0.7
46.8
1383
15923
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
46.7
626
2578
3310A
ICD-9 Finland
Other cerebral degenerations, Alzheimer's disease
+∞
46.1
48
*
SPAT1153
SPAT
Removal of sutures
0.7
45.7
1709
18847
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.2
44.7
511
1967
N07AA05
ATC
NA
381.6
43.5
47
*
E86
ICD-10 Finland
Volume depletion
2.5
43.0
361
1193
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.9
43.0
710
3164
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.7
42.8
1106
5671
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.6
42.4
1137
13386
R42
ICD-10 Finland
Dizziness and giddiness
1.4
42.1
2246
13613
A29
ICPC
General symptom/complaint other
1.7
42.0
1092
5611
B03BA03
ATC
hydroxocobalamin; parenteral
1.8
41.9
774
3584
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.7
41.8
961
4765
F0024, G308
ICD-10 Finland
NA
+∞
40.3
42
*
Z02.7
ICD-10 Finland
Issue of medical certificate
2.0
39.6
567
2394
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.2
39.4
423
1583
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2.6
38.8
313
1013
C10AA01
ATC
simvastatin; oral
1.3
37.8
5050
35425
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
6.1
37.7
109
146
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
4.6
37.0
137
245
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.5
36.7
1765
10438
R33
ICD-10 Finland
Retention of urine
1.6
35.9
1132
6094
N06AB06
ATC
sertraline; oral
1.9
35.8
566
2480
J01DB01
ATC
cefalexin; oral
1.3
35.5
6463
47195
Z29
ICPC
Social problem NOS
3.1
34.2
199
524
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
34.1
1237
6880
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
34.1
2943
19251
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.0
33.8
473
1981
N30.0
ICD-10 Finland
Acute cystitis
1.5
33.3
1200
6663
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.8
33.3
652
3071
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
32.3
1708
10257
SPAT1139
SPAT
Nutrition survey
2.2
32.1
339
1260
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.9
31.8
538
2414
WZC30
NOMESCO Finland
Teaching
0.6
31.6
387
5484
F00.24
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type
28.2
31.4
45
13
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
3.0
31.2
188
507
G31.0
ICD-10 Finland
Circumscribed brain atrophy
5.9
30.7
90
124
A03FA01
ATC
metoclopramide; systemic, rectal
0.7
29.9
893
10371
A04AA02
ATC
granisetron; systemic, transdermal
0.3
29.7
87
2026
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.4
29.7
1579
9482
SPAT1167
SPAT
Insertion of urinary catheter
1.9
28.9
456
1994
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.4
28.9
256
874
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.7
28.7
630
3070
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.2
28.7
308
1154
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
28.5
3072
20621
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.3
28.3
51
1499
WX402
NOMESCO Finland
General anaesthesia
0.6
28.2
387
5331
F00.11
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism
21.9
28.0
43
16
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
1.9
28.0
443
1941
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
3.7
27.8
128
283
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.4
27.7
142
343
F01.2
ICD-10 Finland
Subcortical vascular dementia
4.5
27.6
102
184
S18
ICPC
Laceration/cut
0.8
27.2
2555
24970
F002, G308
ICD-10 Finland
NA
30.9
27.2
38
10
A69
ICPC
General and Unspecified, Other reason for encounter NEC
2.2
27.1
282
1041
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.6
27.0
639
7779
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.4
26.7
244
846
F00.09
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking
40.7
26.5
35
7
J01EA01
ATC
trimethoprim; systemic
1.3
26.5
2193
14140
-2
ICPC
NA
4.2
26.3
106
208
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.4
26.3
1415
8495
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.2
26.1
279
1042
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.2
25.9
35
1195
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.3
25.4
55
1474
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
5.2
25.4
82
128
A10AE04
ATC
insulin glargine; parenteral
1.6
25.3
802
4312
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.5
25.1
1106
6385
SPAT1276
SPAT
Outlining of treatment with patient or their family members
2.2
25.1
258
949
F0012, G301
ICD-10 Finland
NA
+∞
25.0
26
*
Z51.88
ICD-10 Finland
Other specified medical care
2.5
24.6
205
678
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.6
24.5
743
3945
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.0
24.4
321
1313
F00.13
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression
30.7
24.3
34
9
J01CA08
ATC
pivmecillinam; oral
1.3
24.3
2558
17030
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
25.9
24.0
35
11
L82
ICD-10 Finland
Seborrhoeic keratosis
0.7
23.6
664
7823
N28
ICPC
Limited function/disability (N)
2.6
23.5
175
544
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
1.8
23.4
461
2176
R1250
NOMESCO Finland
Evaluation of functional capability
2.7
22.7
163
497
Z28
ICPC
Limited function/disability (Z)
4.4
22.6
86
161
G04BD08
ATC
solifenacin; oral
1.6
22.1
697
3737
F0021, G308
ICD-10 Finland
NA
+∞
22.1
23
*
AXX01
SPAT
NA
2.6
21.9
171
545
E000001
ATC
NA
1.4
21.5
1459
9084
F00.2
ICD-10 Finland
Dementia in Alzheimer disease, atypical or mixed type
33.7
21.3
29
7
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.0
21.1
292
1218
Z13.3
ICD-10 Finland
Special screening examination for mental and behavioural disorders
12.1
21.1
40
27
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.8
21.1
1650
16610
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
20.8
899
5163
J01MA02
ATC
ciprofloxacin; systemic
1.2
20.8
3511
24661
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
0.2
20.7
24
894
F00.01
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism
52.8
20.7
26
*
RD211
NOMESCO Finland
NA
0.4
20.7
66
1479
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
0.2
20.7
18
795
SPAT1050
SPAT
Extensive neurological examination
2.2
20.5
227
864
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
1.7
20.3
439
2131
N07AA06
ATC
NA
+∞
20.2
21
*
F0013, G301
ICD-10 Finland
NA
+∞
20.2
21
*
F0022, G308
ICD-10 Finland
NA
+∞
20.2
21
*
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.4
19.8
99
1857
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
19.8
585
3086
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.7
19.7
1041
11068
F00.12
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations
17.4
19.6
32
15
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.5
19.4
817
4663
SPAT1307
SPAT
Psychosocial counselling and guidance
2.2
19.2
194
709
F0004, G300
ICD-10 Finland
NA
+∞
19.2
20
*
F0023, G308
ICD-10 Finland
NA
+∞
19.2
20
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
2.4
19.1
169
579
F22.0
ICD-10 Finland
Delusional disorder
2.8
18.8
127
374
R11
ICD-10 Finland
Nausea and vomiting
1.5
18.7
622
3377
N29
ICPC
Neurological sympt/complt other
2.3
18.6
176
623
WX212
NOMESCO Finland
Femoral plexus blockade
2.1
18.6
207
793
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
0.7
18.4
565
6564
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.2
18.3
3062
21402
UGC12
NOMESCO Finland
Flexible bronchoscopy
0.6
18.2
414
5096
F009, G301
ICD-10 Finland
NA
+∞
18.2
19
*
F0024, G301
ICD-10 Finland
NA
+∞
18.2
19
*
E0000UV
ATC
NA
1.2
18.2
2804
19421
N30.9
ICD-10 Finland
Cystitis, unspecified
1.6
18.2
469
2392
XX3DW
NOMESCO Finland
Time consuming IT work
0.6
18.1
348
4438
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
4.3
17.9
68
128
N06AX16
ATC
venlafaxine; oral
1.6
17.9
543
2883
SPAT1284
SPAT
Extensive health certificate
2.1
17.9
206
798
A04AA01
ATC
ondansetron; systemic, rectal
0.5
17.8
156
2432
F01.9
ICD-10 Finland
Vascular dementia, unspecified
2.0
17.6
235
967
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.4
17.6
755
4325
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
0.5
17.5
194
2828
4289X
ICD-9 Finland
Heart failure, unspecified
0.1
17.5
*
438
SPAT1263
SPAT
Sampling
1.2
17.4
3334
23606
L01BC06
ATC
capecitabine; oral
0.4
17.3
62
1322
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
6.5
17.1
46
58
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.4
17.1
1099
6766
SPAT1058
SPAT
PEF monitoring instruction
0.6
17.0
266
3553
F00.04
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type
81.3
16.9
20
*
SPAT1279
SPAT
Preparation of immediate hospitalisation
2.4
16.9
148
505
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
2.1
16.9
204
811
JN4AD
NOMESCO Finland
Body CT examination
0.6
16.8
280
3686
2900A
ICD-9 Finland
Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated
5.4
16.8
52
79
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
16.6
2610
18076
K59.0
ICD-10 Finland
Constipation
1.5
16.5
551
2992
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
0.7
16.5
612
6889
N05AB03
ATC
perphenazine; systemic, rectal
2.0
16.5
205
822
Z51.5
ICD-10 Finland
Palliative care
1.5
16.5
636
3566
S00.0
ICD-10 Finland
Superficial injury of scalp
2.1
16.5
184
705
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
2.3
16.4
159
572
P05
ICPC
Senility, feeling/behaving old
3.3
16.4
86
215
C04AE01
ATC
ergoloid mesylates; systemic
2.7
16.3
116
354
H02AA02
ATC
fludrocortisone; oral
2.7
16.3
115
348
A01
ICPC
Pain general/multiple sites
1.5
16.3
590
3263
F00.23
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression
42.6
16.2
21
*
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.4
16.2
883
5287
WF049
NOMESCO Finland
Radiotherapy of metastasis
0.4
16.2
72
1410
LAITO
NOMESCO Finland
NA
13.1
16.1
29
18
H02AB06
ATC
prednisolone; systemic
0.8
15.9
3143
28850
U13
ICPC
Bladder symptom/complaint other
1.9
15.8
253
1118
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
2.0
15.8
207
850
G91.0
ICD-10 Finland
Communicating hydrocephalus
4.0
15.8
65
133
C03CA01
ATC
furosemide; systemic
1.2
15.8
3957
28681
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
4.1
15.7
62
122
N06AX21
ATC
duloxetine; oral
1.5
15.7
538
2943
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.3
15.6
1288
8234
L08
ICPC
Shoulder symptom/complaint
0.7
15.6
803
8589
Y94.1
ICD-10 Finland
Accident in connection with service housing
10.5
15.5
31
24
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
0.5
15.5
106
1780
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
4.9
15.5
52
87
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.4
15.3
74
1403
N03AX14
ATC
levetiracetam; systemic
2.1
15.3
183
726
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.2
15.2
2530
17595
F05.0
ICD-10 Finland
Delirium not superimposed on dementia, so described
4.3
15.2
58
111
SPAT1262
SPAT
Handing over of treatment supplies
1.3
15.1
1553
10218
WF002
NOMESCO Finland
Radical radiotherapy
0.5
15.1
148
2229
L15
ICPC
Knee symptom/complaint
0.8
15.0
927
9669
Z60.8
ICD-10 Finland
Other problems related to social environment
5.0
14.9
49
80
W06
ICD-10 Finland
Fall involving bed
2.7
14.9
101
301
Y94.0
ICD-10 Finland
Accident at home
2.1
14.8
172
673
R03AC02
ATC
salbutamol; inhalant
0.8
14.7
2959
27172
M01AH05
ATC
etoricoxib; oral
0.8
14.7
2699
24989
S01
ICD-10 Finland
Open wound of head
2.5
14.7
116
376
H25.1
ICD-10 Finland
Senile nuclear cataract
1.2
14.6
3453
24839
S15
ICPC
Foreign body in skin
0.6
14.6
176
2504
F009, F03
ICD-10 Finland
NA
12.2
14.6
27
18
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
2.3
14.4
132
461
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.6
14.4
379
1945
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.3
14.4
938
5783
F000, G300
ICD-10 Finland
NA
+∞
14.4
15
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.4
14.4
624
3583
P29
ICPC
Psychological sympt/compl other
2.0
14.4
178
715
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
0.7
14.4
526
5932
F00.0
ICD-10 Finland
Dementia in Alzheimer disease with early onset
48.7
14.3
18
*
K08.3
ICD-10 Finland
Retained dental root
1.5
14.2
485
2648
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
9.0
14.0
30
27
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
1.9
13.9
206
887
G46.8*I67.9
ICD-10 Finland
Other vascular syndromes of brain in cerebrovascular diseases
5.8
13.9
40
56
N05CD07
ATC
temazepam; oral
1.3
13.9
1374
8987
PJA12
NOMESCO Finland
Sentinel node biopsy
0.6
13.9
179
2507
DFF00
NOMESCO Finland
Pure tone audiometry
0.7
13.8
385
4559
HMAK
NOMESCO Finland
NA
0.6
13.8
289
3620
Z51.0
ICD-10 Finland
Radiotherapy session
0.2
13.8
11
509
G04CA01
ATC
alfuzosin; oral
1.3
13.8
1204
7748
XF606
NOMESCO Finland
Ortostatic test
2.8
13.8
90
263
S28
ICPC
Limited function/disability (S)
3.3
13.7
69
168
G04CB02
ATC
dutasteride; oral
1.4
13.7
780
4703
A10AE05
ATC
insulin detemir; parenteral
1.6
13.7
397
2086
A06AC01
ATC
ispaghula (psylla seeds); oral
1.2
13.7
2041
14010
G31.1
ICD-10 Finland
Senile degeneration of brain, not elsewhere classified
6.5
13.6
36
45
N17
ICPC
Vertigo/dizziness
1.3
13.6
964
6017
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
0.8
13.4
1524
14810
F0019, G309
ICD-10 Finland
NA
+∞
13.4
14
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
0.3
13.4
31
798
J96.1
ICD-10 Finland
Chronic respiratory failure
0.5
13.4
82
1430
R32
ICD-10 Finland
Unspecified urinary incontinence
1.8
13.3
249
1160
SPAT1111
SPAT
Planning of analgesia
2.5
13.2
108
359
R06.0
ICD-10 Finland
Dyspnoea
0.8
13.2
1669
16043
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
2.0
13.1
177
735
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
0.6
13.1
217
2861
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
1.9
13.0
181
763
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
2.8
13.0
85
248
P04
ICPC
Feeling/behaving irritable/angry
6.6
13.0
34
42
F00.21
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism
17.1
13.0
21
10
A78
ICPC
Infectious disease other/NOS
2.7
13.0
89
268
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
0.6
13.0
219
2872
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
0.5
13.0
104
1658
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
0.4
12.9
41
917
SPAT1125
SPAT
Stoma care and guidance
1.9
12.8
181
768
R50.9
ICD-10 Finland
Fever, unspecified
1.3
12.8
1052
6709
F00, F03
ICD-10 Finland
NA
8.1
12.8
29
29
P28
ICPC
Limited function/disability (P)
3.7
12.7
56
123
N99
ICPC
Neurological disease other
2.5
12.7
98
316
N05CF01
ATC
zopiclone; oral
1.2
12.6
2995
21483
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.2
12.5
132
497
N02AX02
ATC
tramadol; systemic, rectal
0.8
12.4
2774
25344
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.4
12.4
514
2925
S01.8
ICD-10 Finland
Open wound of other parts of head
2.4
12.4
110
380
F05.8
ICD-10 Finland
Other delirium
2.6
12.4
89
276
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
2.8
12.4
78
224
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
12.3
1132
7330
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.7
12.3
267
1302
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.5
12.1
419
2297
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
0.7
12.1
418
4760
WW500
NOMESCO Finland
Blood transfusion
0.5
12.0
121
1806
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.7
12.0
422
4796
S82
ICPC
Naevus/mole
0.7
12.0
434
4907
M70.6
ICD-10 Finland
Trochanteric bursitis
0.7
11.9
509
5607
KMAK
NOMESCO Finland
NA
1.2
11.9
2786
19929
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.8
11.9
1230
12087
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
0.3
11.8
18
570
CA1TM
NOMESCO Finland
Calculation of intraocular lens power
0.4
11.5
44
910
N27
ICPC
Fear of neurological disease other
2.1
11.5
128
494
F0001, G300
ICD-10 Finland
NA
+∞
11.5
12
*
N05AH02
ATC
clozapine; systemic
3.7
11.4
50
110
F00.29
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms
13.5
11.4
20
12
F00.22
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations
15.4
11.4
19
10
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
0.3
11.4
17
545
I95.9
ICD-10 Finland
Hypotension, unspecified
2.0
11.4
147
604
T05
ICPC
Feeding problem of adult
3.5
11.4
53
123
WX111
NOMESCO Finland
Local infiltration anesthesia
0.5
11.4
70
1214
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
0.2
11.3
13
483
115
Kela drug reimbursment
Breast cancer
0.6
11.2
211
2702
L75
ICPC
Fracture: femur
2.0
11.2
141
571
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
0.6
11.2
131
1877
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
0.6
11.2
145
2025
SPAT1014
SPAT
Treatment of eyes
1.9
11.2
170
743
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
2.5
11.1
85
274
N18
ICPC
Paralysis/weakness
1.8
11.1
179
798
G04BD07
ATC
tolterodine; oral
1.4
11.1
515
2998
S42.2
ICD-10 Finland
Fracture of upper end of humerus
1.5
11.1
363
1967
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
0.4
11.1
54
1017
L57.0
ICD-10 Finland
Actinic keratosis
0.8
11.1
705
7337
S01BC05
ATC
ketorolac; ophthalmic
1.4
11.1
484
2785
JN4BD
NOMESCO Finland
Extensive body CT
0.7
11.1
553
5948
CBB11
NOMESCO Finland
Resection of lax skin in upper eyelid
0.4
11.0
38
818
Z75.0
ICD-10 Finland
Medical services not available in home
4.3
11.0
41
78
R29.6
ICD-10 Finland
Tendency to fall, not elsewhere classified
3.3
11.0
55
135
D12
ICPC
Constipation
1.6
10.9
305
1590
AA1AD
SPAT
NA
5.4
10.9
33
50
ZX120
NOMESCO Finland
Intravenous
0.7
10.8
399
4500
S22.3
ICD-10 Finland
Fracture of rib
1.4
10.8
486
2810
WF003
NOMESCO Finland
Adjuvant radiotherapy
0.5
10.7
71
1201
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
1.6
10.7
303
1588
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
3.8
10.7
45
96
A10BB12
ATC
glimepiride; oral
1.3
10.7
839
5315
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
0.2
10.7
10
420
R01AD12
ATC
fluticasone furoate; nasal
0.8
10.7
785
8027
L03AA13
ATC
pegfilgrastim; parenteral
0.4
10.6
59
1059
J01.0
ICD-10 Finland
Acute maxillary sinusitis
0.7
10.6
582
6176
F0021, G301
ICD-10 Finland
NA
+∞
10.6
11
*
F009, G308
ICD-10 Finland
NA
+∞
10.6
11
*
F0009, G309
ICD-10 Finland
NA
+∞
10.6
11
*
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
1.7
10.5
220
1063
F10.73
ICD-10 Finland
Residual or late-onset psychosis caused by alcohol dementia
4.9
10.5
34
56
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
3.3
10.5
52
127
4148X
ICD-9 Finland
Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]
0.3
10.5
26
646
L90
ICPC
Osteoarthrosis of knee
0.7
10.5
241
2959
K86
ICPC
Hypertension uncomplicated
0.8
10.5
674
7006
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
0.4
10.5
43
862
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
2.0
10.4
129
523
R2110
NOMESCO Finland
Giving the first information
1.5
10.4
362
1990
SPAT1043
SPAT
Audiometry
0.8
10.4
648
6765
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
2.0
10.4
139
580
A05
ICPC
Feeling ill
1.6
10.4
258
1309
K80
ICPC
Cardiac arrhythmia NOS
0.7
10.4
294
3466
NF1AA
NOMESCO Finland
Hip X-ray examination
1.3
10.3
777
4896
L01
ICPC
Neck symptom/complaint
0.7
10.3
472
5142
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
3.9
10.2
42
88
D19
ICPC
Teeth/gum symptom/complaint
0.8
10.2
791
8041
R03BA08
ATC
ciclesonide; inhalant
0.6
10.2
202
2558
KED22
NOMESCO Finland
Transurethral resection of prostate
1.3
10.2
797
5046
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
1.8
10.2
182
841
A10BK03
ATC
empagliflozin; oral
0.6
10.2
168
2213
TPX10
NOMESCO Finland
Implantation of vascular injection port
0.4
10.2
53
972
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.8
10.1
2200
20219
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.5
10.1
330
1792
A23
ICPC
Risk factor NOS
1.6
10.0
278
1449
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
1.7
10.0
225
1110
XCH00
NOMESCO Finland
Eye pressure measurement
0.6
10.0
145
1966
C03DA01
ATC
spironolactone; oral
0.8
10.0
711
7299
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
0.2
10.0
11
418
AA1AA
NOMESCO Finland
Head X-ray examination
2.4
10.0
81
271
F09
ICD-10 Finland
Unspecified organic or symptomatic mental disorder
7.2
10.0
24
27
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
0.7
9.9
280
3305
G72.8
ICD-10 Finland
Other specified myopathies
1.9
9.9
147
636
L03AA02
ATC
filgrastim; parenteral
0.4
9.9
45
867
R45.5
ICD-10 Finland
Hostility
12.2
9.9
18
12
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
4.0
9.9
39
79
Z11
ICPC
Compliance/being ill problem
2.9
9.9
61
173
R40.2
ICD-10 Finland
Coma, unspecified
2.3
9.8
88
308
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
0.7
9.8
265
3150
C10AA07
ATC
rosuvastatin; oral
0.8
9.8
1311
12573
L03
ICPC
Low back symptom/complaint
0.8
9.8
1089
10633
K59.09
ICD-10 Finland
Constipation, unspecified
1.4
9.8
537
3222
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
0.5
9.7
62
1060
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.9
9.7
2447
22251
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.5
9.7
320
1738
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
1.7
9.7
213
1047
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
4.1
9.5
37
74
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.5
9.5
57
997
A04AA55
ATC
palonosetron, combinations; systemic
0.2
9.5
12
418
U28
ICPC
Limited function/disability (U)
2.0
9.5
111
442
Z20.8
ICD-10 Finland
Contact with and exposure to other communicable diseases
1.8
9.4
171
793
EBA30
NOMESCO Finland
Excision of root of tooth
1.5
9.4
369
2083
HA1RA
SPAT
NA
0.2
9.3
10
387
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.5
9.3
59
1014
SPAT1098
SPAT
Exercise ECG
0.4
9.3
36
738
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
0.6
9.3
121
1686
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.8
9.3
942
9295
65000
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
0.8
9.3
775
7808
S32.8
ICD-10 Finland
Fracture of other and unspecified parts of lumbar spine and pelvis
2.1
9.3
100
384
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
9.3
3389
25002
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
1.3
9.2
978
6439
R1250
SPAT
NA
3.0
9.2
52
139
SPAT1157
SPAT
Guidance concerning treatment of mouth and mucous membranes
2.1
9.2
106
418
N05AX12
ATC
aripiprazole; systemic
2.6
9.1
68
216
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
0.5
9.1
89
1334
SPAT1285
SPAT
Provision of consultation response
1.4
9.1
403
2330
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.7
9.1
290
3344
G40
ICD-10 Finland
Epilepsy
3.1
9.0
51
136
R44.3
ICD-10 Finland
Hallucinations, unspecified
3.1
9.0
51
136
M04AA01
ATC
allopurinol; systemic
0.8
9.0
1031
10049
WX199
NOMESCO Finland
Other local analgesia
0.5
9.0
77
1200
Z43.5
ICD-10 Finland
Attention to cystostomy
2.4
9.0
74
250
D07AA02
ATC
hydrocortisone; topical
1.3
9.0
816
5273
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
3.3
9.0
44
108
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.8
9.0
56
161
N05AA02
ATC
levomepromazine; systemic
1.6
8.9
249
1302
S42.0
ICD-10 Finland
Fracture of clavicle
1.8
8.9
156
717
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.2
8.9
1223
8287
S06.3
ICD-10 Finland
Focal brain injury
2.0
8.9
113
466
SPAT1042
SPAT
Guidance concerning balance maintenance
2.6
8.9
64
202
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
0.3
8.9
18
490
SPAT1236
SPAT
Informing family of child’s disability
1.7
8.8
164
768
T03
ICPC
Loss of appetite
3.9
8.8
36
76
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
0.5
8.8
59
991
R45.1
ICD-10 Finland
Restlessness and agitation
4.9
8.8
28
46
F00.02
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions
44.6
8.8
11
*
SPAT1104
SPAT
Monitoring of emergency patient
1.4
8.7
516
3134
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.2
8.7
1257
8561
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.8
8.7
143
646
I48.1
ICD-10 Finland
Persistent atrial fibrillation
0.6
8.7
106
1496
ZXA00
NOMESCO Finland
Right side
1.2
8.7
2346
16902
IAB14
NOMESCO Finland
Geriatric psychiatry consultation
4.3
8.6
31
58
R63.4
ICD-10 Finland
Abnormal weight loss
1.5
8.6
282
1534
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.8
8.6
1082
10449
C10AX09
ATC
ezetimibe; oral
0.8
8.6
480
5084
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
0.8
8.6
1214
11596
DAX08
NOMESCO Finland
Fitting of hearing aid
0.7
8.6
227
2707
C10AA02
ATC
lovastatin; oral
1.4
8.6
499
3024
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.5
8.6
266
1430
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
1.9
8.5
122
525
NFB10
NOMESCO Finland
Primary partial prosthetic replacement of hip joint not using cement, other or unspecified
2.8
8.5
53
153
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.5
8.4
290
1594
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
0.6
8.4
174
2179
R21
ICPC
Throat symptom/complaint
0.7
8.3
444
4731
K22
ICPC
Risk factor cardiovascular disease
0.7
8.2
221
2631
R05
ICPC
Cough
0.8
8.2
1020
9865
Z73.6
ICD-10 Finland
Limitation of activities due to disability
2.2
8.2
78
284
T08
ICPC
Weight loss
1.9
8.2
112
474
SPAT1138
SPAT
Guidance concerning bowel function
1.8
8.2
127
560
180
Kela drug reimbursment
Interferon alfa
0.0
8.2
*
168
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.4
8.2
382
2230
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
2.2
8.1
79
289
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
2.2
8.1
79
289
C09AA05
ATC
ramipril; oral
1.2
8.1
2522
18347
HA1AA
NOMESCO Finland
X-ray mammography
0.7
8.1
193
2349
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
0.6
8.1
103
1439
G20
ICD-10 Finland
Parkinson disease
1.4
8.1
330
1880
A69.2
ICD-10 Finland
Lyme disease
0.6
8.0
125
1666
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
0.8
8.0
502
5240
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.3
8.0
599
3769
SDA02
NOMESCO Finland
Parodonthologic therapy
0.8
8.0
1283
12127
K90
ICPC
Stroke/cerebrovascular accident
1.5
8.0
276
1519
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
0.6
8.0
111
1518
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.5
8.0
302
1694
R26
ICD-10 Finland
Abnormalities of gait and mobility
3.7
8.0
34
75
Z03
ICPC
Housing/neighbourhood problem
2.7
8.0
54
163
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
1.7
8.0
158
757
WX404
NOMESCO Finland
Intravenous generell anesthesy
0.8
8.0
833
8194
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.3
8.0
685
4395
R54
ICD-10 Finland
Senility
2.5
7.9
61
199
F32
ICD-10 Finland
Depressive episode
1.6
7.9
181
901
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.7
7.9
54
165
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
0.8
7.9
1197
11367
R74
ICPC
Upper respiratory infection acute
0.8
7.9
681
6839
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
3.0
7.9
45
123
F00.03
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression
40.6
7.9
10
*
E53.8
ICD-10 Finland
Deficiency of other specified B group vitamins
2.4
7.9
62
207
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
1.9
7.9
113
489
S12
ICPC
Insect bite/sting
0.7
7.8
312
3469
SPAT1244
SPAT
Occupational therapy
2.1
7.8
87
340
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
0.3
7.8
16
435
XA400
NOMESCO Finland
EEG
2.7
7.8
51
153
TK800
NOMESCO Finland
Hemodialysis
0.4
7.8
42
760
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.4
7.8
445
2688
Z60.9
ICD-10 Finland
Problem related to social environment, unspecified
3.3
7.8
38
94
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.3
7.8
815
5360
A12AA04
ATC
calcium carbonate; oral
0.4
7.7
32
637
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
0.4
7.7
32
637
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
0.2
7.7
10
344
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
0.6
7.7
165
2050
N03AF02
ATC
oxcarbazepine; oral
1.6
7.7
179
897
L13
ICPC
Hip symptom/complaint
0.8
7.7
880
8581
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.0
7.7
44
121
R31
ICD-10 Finland
Unspecified haematuria
1.2
7.7
1057
7165
K91
ICPC
Cerebrovascular disease
1.8
7.6
132
609
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.4
7.6
355
2073
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
0.6
7.6
115
1538
L02BG04
ATC
letrozole; oral
0.6
7.5
139
1779
D82
ICPC
Teeth/gum disease
0.8
7.5
1157
10972
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.2
7.5
2223
16103
T90.5
ICD-10 Finland
Sequelae of intracranial injury
2.3
7.5
65
229
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
0.6
7.4
147
1857
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
0.7
7.4
218
2552
R03BB01
ATC
ipratropium bromide; inhalant
0.7
7.4
319
3505
N81.1
ICD-10 Finland
Cystocele
0.7
7.4
207
2443
SPAT1059
SPAT
Spirometry at the office
0.7
7.4
185
2226
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
0.7
7.4
211
2478
M05BA02
ATC
clodronic acid; systemic
0.2
7.4
6
274
G04BD10
ATC
darifenacin; oral
2.3
7.4
67
241
Z49.1
ICD-10 Finland
Extracorporeal dialysis
0.3
7.4
20
472
C01DA14
ATC
isosorbide mononitrate; oral
1.2
7.4
2247
16307
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
0.3
7.3
15
405
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
1.7
7.3
160
788
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
0.9
7.3
2362
21188
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
0.4
7.3
35
661
WX302
NOMESCO Finland
Thoracal epidural anesthesy
0.7
7.3
162
1994
F01
ICD-10 Finland
Vascular dementia
2.7
7.3
50
153
A96
ICPC
Death
2.4
7.3
60
205
HAB99
NOMESCO Finland
Other partial excision of mammary gland
0.4
7.2
29
583
A01AB09
ATC
miconazole; local oral
1.3
7.2
686
4457
SDA01
NOMESCO Finland
Simple parodonthologic therapy
0.8
7.2
860
8353
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
2.0
7.2
91
374
R35
ICD-10 Finland
Polyuria
1.3
7.2
523
3281
G04BX04
ATC
NA
1.5
7.2
241
1319
B01AC24
ATC
ticagrelor; oral
0.6
7.2
90
1263
S21
ICPC
Skin texture symptom/complaint
0.8
7.2
597
6017
TGC00
NOMESCO Finland
Bronchial lavation
0.5
7.1
63
970
B01AA03
ATC
warfarin; systemic
1.1
7.1
2601
19114
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
0.5
7.1
50
824
R44.1
ICD-10 Finland
Visual hallucinations
2.6
7.1
49
152
N04AA02
ATC
biperiden; systemic
1.9
7.1
100
429
NFJ52
NOMESCO Finland
Internal fixation of fracture of upper femur with screws and sideplate
1.9
7.1
98
418
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.3
7.0
642
4152
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
0.7
7.0
327
3552
UKC02
NOMESCO Finland
Cystoscopy
1.2
7.0
1717
12253
XJH00
NOMESCO Finland
Transanal ultrasonography
1.2
7.0
749
4938
LCA06
NOMESCO Finland
Biopsy of endometrium
0.7
7.0
226
2599
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
0.6
7.0
81
1159
E87.6
ICD-10 Finland
Hypokalaemia
1.5
7.0
218
1178
L04AX01
ATC
azathioprine; systemic
0.6
7.0
87
1222
S32.4
ICD-10 Finland
Fracture of acetabulum
2.2
7.0
66
240
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.2
7.0
752
4962
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
0.2
7.0
7
277
N05AL01
ATC
sulpiride; systemic
1.9
7.0
98
423
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
0.5
7.0
53
855
P99
ICPC
Psychological disorders other
2.2
7.0
71
268
F99
ICD-10 Finland
Mental disorder, not otherwise specified
2.5
7.0
53
175
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.5
7.0
251
1396
S20.2
ICD-10 Finland
Contusion of thorax
1.4
6.9
306
1772
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
0.1
6.9
*
209
SPAT1281
SPAT
Other administrative function
1.3
6.9
513
3226
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
2.2
6.9
68
252
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
0.7
6.9
312
3404
G04BD11
ATC
fesoterodine; oral
1.4
6.9
269
1520
WVA30
SPAT
NA
0.5
6.9
47
782
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
6.6
6.8
17
21
T68
ICD-10 Finland
Hypothermia
2.7
6.8
44
131
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
0.7
6.8
177
2117
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
3.5
6.8
30
69
G47.3
ICD-10 Finland
Sleep apnoea
0.8
6.8
778
7585
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
6.8
1902
13710
G04BD12
ATC
mirabegron; oral
1.2
6.8
887
5980
B01AC07
ATC
dipyridamole; systemic
1.3
6.7
699
4591
Z74.1
ICD-10 Finland
Need for assistance with personal care
8.7
6.7
14
13
R03DA04
ATC
theophylline; systemic, rectal
0.8
6.7
441
4572
F0010, G308
ICD-10 Finland
NA
+∞
6.7
7
*
F0022, G301
ICD-10 Finland
NA
+∞
6.7
7
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.9
6.7
1763
16047
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
0.4
6.7
35
635
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
2.1
6.6
74
292
TQW40
SPAT
NA
0.5
6.6
60
916
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.2
6.6
954
6494
N05BE01
ATC
buspirone; oral
1.7
6.6
126
598
A04AD12
ATC
aprepitant; systemic
0.3
6.6
12
343
H01
ICPC
Ear pain/earache
0.7
6.6
278
3064
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.3
6.6
416
2559
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
0.4
6.6
25
513
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
0.6
6.6
71
1032
128
Kela drug reimbursment
Cancers of female genital organs
0.4
6.6
21
461
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
0.3
6.6
13
356
207
Kela drug reimbursment
Chronic arrhythmias
0.9
6.6
1293
12025
SPAT1109
SPAT
Analgesia with portable analgesic pump
2.4
6.6
55
189
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
0.6
6.5
137
1705
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
0.8
6.5
469
4810
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
1.6
6.5
165
847
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.6
6.5
168
866
R03AK07
ATC
formoterol and budesonide; inhalant
0.8
6.5
715
7000
G91.1
ICD-10 Finland
Obstructive hydrocephalus
3.2
6.5
33
85
S06.2
ICD-10 Finland
Diffuse brain injury
2.1
6.5
70
271
A11CC03
ATC
alfacalcidol; systemic
0.5
6.5
66
976
HAB40
NOMESCO Finland
Wedge excision of mammary gland
0.6
6.5
122
1552
201
Kela drug reimbursment
Chronic cardiac insufficiency
0.8
6.5
400
4179
T93
ICPC
Lipid disorder
0.7
6.5
193
2248
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.8
6.5
644
6367
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.5
6.4
239
1340
G21.0
ICD-10 Finland
Malignant neuroleptic syndrome
7.2
6.4
15
17
SGC00
NOMESCO Finland
Local medication of root channels of tooth
0.7
6.4
192
2234
Z01.2
ICD-10 Finland
Dental examination
0.9
6.4
1605
14668
K03.64
ICD-10 Finland
Dental calculus supragingival
0.8
6.4
824
7946
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.8
6.4
99
443
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
2.7
6.4
41
122
HA1RA
NOMESCO Finland
Combined assessment of mammary gland (mammography and ultrasound)
0.3
6.4
11
325
F16
ICPC
Eyelid symptom/complaint
0.6
6.4
128
1608
P15
ICPC
Chronic alcohol abuse
2.0
6.4
80
330
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
0.6
6.3
78
1094
GD1AA
SPAT
NA
0.5
6.3
60
903
N81.6
ICD-10 Finland
Rectocele
0.7
6.3
193
2237
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
3.7
6.3
26
57
I50.9
ICD-10 Finland
Heart failure, unspecified
1.2
6.3
1841
13302
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.2
6.3
1177
8209
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
0.7
6.3
151
1830
H04AA01
ATC
glucagon; nasal, parenteral
2.1
6.3
71
281
4402A
ICD-9 Finland
Atherosclerosis, Of native arteries of the extremities
0.6
6.3
70
1009
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
1.6
6.3
167
871
EBA00
NOMESCO Finland
Extraction of tooth
1.1
6.3
1885
13648
M19.0
ICD-10 Finland
Primary arthrosis of other joints
0.8
6.3
348
3683
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
0.3
6.3
15
376
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.8
6.2
37
106
I95.0
ICD-10 Finland
Idiopathic hypotension
3.4
6.2
28
66
F06.0
ICD-10 Finland
Organic hallucinosis
3.4
6.2
28
66
S72.2
ICD-10 Finland
Subtrochanteric fracture
1.9
6.2
86
370
N84.0
ICD-10 Finland
Polyp of corpus uteri
0.7
6.2
168
1989
D17
ICPC
Incontinence of bowel
2.0
6.2
71
284
A77
ICPC
Viral disease other/NOS
0.4
6.2
21
450
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
0.7
6.2
174
2047
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
1.8
6.2
95
421
R12
ICD-10 Finland
Heartburn
0.7
6.2
200
2298
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
1.4
6.2
326
1950
Z02.8
ICD-10 Finland
Other examinations for administrative purposes
3.0
6.2
35
96
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
0.7
6.2
245
2719
ACC51
NOMESCO Finland
Release of median nerve
0.7
6.2
195
2247
Z46.9
ICD-10 Finland
Fitting and adjustment of unspecified device
1.7
6.2
111
519
B01AF01
ATC
rivaroxaban; oral
0.8
6.1
705
6874
G04BD04
ATC
oxybutynin; oral, transdermal
1.3
6.1
517
3315
F0289, G318
ICD-10 Finland
NA
32.4
6.1
8
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
0.4
6.1
19
421
Z08
ICPC
Social welfare problem
2.1
6.1
65
252
ZXC96
NOMESCO Finland
Robot assisted procedure
0.5
6.1
38
648
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
0.7
6.1
138
1687
L01CA04
ATC
vinorelbine; systemic
0.3
6.1
9
285
Z51.4
ICD-10 Finland
Preparatory care for subsequent treatment, not elsewhere classified
1.9
6.1
80
337
F30.1
ICD-10 Finland
Mania without psychotic symptoms
6.4
6.0
15
19
E000003
ATC
NA
1.4
6.0
243
1386
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
610
344
13.96
307.65
1.0
1.0
ng/l
416.0
297.7
9.35
449
194
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
617
345
14.09
307.65
1.0
1.0
ng/l
57.8
40.6
7.99
447
194
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
617
346
14.05
307.65
1.0
1.0
ng/l
537.9
702.6
8.58
440
189
(3019309) Folate [Moles/volume] in Red Blood Cells
5017
20899
2.31
307.65
2.0
1.8
nmol/l
1201.4
1160.4
2.10
3554
15422
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
574
1029
4.35
199.27
1.2
1.4
e6/l
246.5
1239.9
3.64
453
862
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
574
1029
4.35
199.27
1.2
1.3
e6/l
11.8
21.7
0.57
442
815
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
632
1222
4.04
199.23
1.1
1.3
mg/l
468.8
600.8
4.41
566
1155
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
566
1069
4.12
183.81
1.1
1.2
mmol/l
3.8
3.9
0.90
525
988
(3044290) Cell count panel - Cerebral spinal fluid
492
947
4.03
155.66
1.2
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
388
712
4.20
130.43
3.1
3.6
umol/l
306.5
326.2
1.56
302
575
(40768804) Tissue Pathology biopsy report
2494
28534
0.58
122.94
2.2
2.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
280
410
5.24
122.32
1.3
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
3410
17288
1.66
122.04
3.1
3.0
mmol/l
2.5
2.5
8.39
2900
14734
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1255
16772
0.52
103.11
1.5
1.6
mmol/l
1.2
1.3
2.32
1053
13639
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
6997
62361
0.67
101.68
3.8
4.8
mmol/l
1.4
1.4
0.48
5808
54801
(3015377) Calcium [Moles/volume] in Serum or Plasma
4979
28479
1.51
101.60
2.6
3.2
mmol/l
2.3
2.4
0.84
4111
23760
(3020682) Albumin/Creatinine [Ratio] in Urine
2411
26673
0.61
97.90
3.2
3.9
mg/mmol
11.8
10.3
0.64
1429
16791
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
6756
60339
0.68
95.73
3.4
4.3
mmol/l
1.2
1.2
1.97
5515
52374
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
7156
63137
0.68
93.84
3.8
4.8
mmol/l
4.3
4.3
1.50
5995
56008
(3012516) Albumin [Mass/volume] in Urine
2252
25039
0.61
92.00
2.6
3.2
mg/l
491.2
391.9
0.43
1357
15985
(3009508) Creatinine [Moles/volume] in Urine
2265
25075
0.61
90.50
2.5
3.1
mmol/l
7.0
6.6
2.83
1705
20245
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
6086
37332
1.42
80.01
2.5
2.2
pmol/l
89.6
92.6
5.21
3124
19201
(3031040) Bacteria [#/volume] in Urine by Automated count
8078
52541
1.41
72.92
6.3
5.6
e6/l
3787.9
1523.5
2.26
259
938
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
7625
65383
0.71
71.68
4.4
5.5
mmol/l
2.4
2.4
2.30
6433
57769
(3023368) Bacteria identified in Blood by Culture
4529
26836
1.41
69.07
4.0
4.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
4991
30091
1.40
68.81
3.9
3.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
3446
19570
1.44
65.72
1.8
1.8
pmol/l
438.5
20164135.6
8.55
2657
15394
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
7250
62267
0.73
64.32
19.7
19.0
ml/min/173m2
66.4
66.7
0.65
5656
51991
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
2150
11163
1.54
63.59
1.9
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
2136
11218
1.52
59.51
1.9
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
647
9034
0.52
57.49
1.2
1.2
u/ml
17.3
16.2
0.09
159
2931
(3016018) Differential panel - Cerebral spinal fluid
219
483
3.46
57.19
1.2
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
5874
37162
1.34
55.99
3.7
4.4
g/l
34.0
33.9
0.46
5154
33855
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2853
16267
1.41
50.94
1.9
1.9
—
—
—
0
0
(4035726)
456
6799
0.49
49.14
1.3
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
753
9615
0.57
48.68
1.2
1.3
iu/ml
44.1
42.7
0.08
216
2956
(1761868) Lipid panel - Serum or Plasma
1433
15646
0.65
47.89
3.2
3.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1190
5757
1.61
46.73
1.6
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
3788
23016
1.34
44.37
1.7
1.6
nmol/l
20.1
20.2
0.11
3319
19305
(3019150) Specific gravity of Urine by Refractometry
2819
16513
1.36
41.46
5.6
5.0
kg/l
1.0
1.0
0.99
438
2782
(3037522) Nuclear Ab [Titer] in Serum
573
7493
0.56
39.90
1.2
1.3
titre
447.5
532.0
0.69
112
1767
(3002179) Metamyelocytes/100 leukocytes in Blood
413
5953
0.51
39.81
2.9
3.5
%
0.7
0.6
0.14
87
1419
(3017181) Myelocytes/100 leukocytes in Blood
486
6648
0.53
39.54
3.1
3.6
%
1.2
0.9
0.56
142
2047
(3021440) Promyelocytes/100 leukocytes in Blood
452
6318
0.52
39.50
3.1
3.6
%
0.2
0.1
0.82
128
1907
(3026493) Urate [Moles/volume] in Serum or Plasma
2070
20431
0.72
38.50
2.3
2.9
umol/l
10206.7
7355.6
1.17
1593
16885
(3021589) Normoblasts [#/volume] in Blood
3345
30715
0.76
37.92
9.4
10.9
e9/l
0.0
0.0
1.31
2632
24903
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
3868
34794
0.77
37.30
4.0
4.4
—
—
—
0
0
(3002256) Pathology report gross observation
859
9955
0.63
36.84
1.4
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
421
5830
0.53
35.55
3.1
3.6
%
0.0
0.4
2.83
106
1576
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
7655
63249
0.79
35.06
6.3
7.0
mmol/mol
42.7
41.5
14.34
6530
56516
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
370
5286
0.51
34.54
1.3
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
686
3124
1.69
33.82
1.2
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1569
15856
0.71
32.91
1.2
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
622
7535
0.60
31.96
1.2
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
7987
65388
0.80
31.56
4.5
5.4
mmol/l
6.2
6.1
5.08
6635
57124
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
4701
30494
1.25
30.12
2.1
2.2
nmol/l
78.2
80.8
6.59
3873
26019
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
874
9633
0.66
29.14
4.1
4.9
%
34.3
34.3
0.02
450
6095
(40768797) Stomach Pathology biopsy report
913
9963
0.67
28.94
1.2
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
3837
33721
0.80
27.66
4.5
5.5
%
2.8
2.8
0.07
3388
30779
(3018010) Neutrophils/100 leukocytes in Blood
3838
33724
0.80
27.61
4.6
5.5
%
61.4
59.8
10.85
3389
30811
(3006315) Basophils [#/volume] in Blood
4105
35800
0.80
27.55
4.3
5.2
e9/l
0.0
0.0
1.92
3367
30096
(3022096) Basophils/100 leukocytes in Blood
3731
32877
0.80
27.51
4.5
5.5
%
0.6
0.6
3.09
3290
30059
(3019069) Monocytes/100 leukocytes in Blood
3860
33885
0.80
27.49
4.8
5.8
%
8.9
9.0
0.68
3412
31010
(3001604) Monocytes [#/volume] in Blood
4077
35527
0.80
26.96
4.3
5.2
e9/l
0.6
0.6
0.41
3337
29818
(3013512) EKG study
2797
25419
0.78
26.75
4.4
4.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
5884
39441
1.22
26.69
4.5
5.8
mmol/l
1.2
1.2
3.57
5082
35101
(3013115) Eosinophils [#/volume] in Blood
4248
36811
0.81
26.50
4.4
5.3
e9/l
0.2
0.2
0.11
3471
31355
(3018418) pH of Serum or Plasma
4026
25954
1.24
26.31
3.0
4.0
ph
7.4
7.4
1.25
639
4947
(3002030) Lymphocytes/100 leukocytes in Blood
3947
34367
0.81
25.42
4.8
5.8
%
23.3
24.7
10.54
3454
31239
(3019198) Lymphocytes [#/volume] in Blood
4209
36334
0.81
24.71
4.4
5.3
e9/l
1.7
1.9
2.26
3467
31005
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
5207
34650
1.22
24.68
4.7
4.6
ng/l
59.5
95.0
1.58
4093
28061
(3000492) Spirometry study
364
4733
0.57
24.46
1.4
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
4897
41599
0.82
24.33
5.8
8.0
e9/l
4.8
4.5
11.26
4089
35647
(40760892) CBC W Ordered Manual Differential panel - Blood
1384
13612
0.74
23.49
3.6
4.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
429
5287
0.60
23.42
1.5
1.5
—
—
—
0
0
(4010399)
413
5136
0.59
23.37
1.4
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
4012
26105
1.23
23.36
2.3
2.1
u/l
264.0
222.5
2.06
3655
24202
(40761535) Cells panel - Urine sediment
1307
7381
1.37
22.94
4.0
3.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
3181
20262
1.24
22.44
5.3
4.9
estimate
0.0
0.0
1.15
692
6499
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
973
10027
0.71
22.10
2.6
3.6
ug/l
21.1
23.0
0.09
777
8407
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2074
19116
0.78
21.39
2.3
2.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
4290
28316
1.21
21.10
2.6
2.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
7363
51084
1.20
20.97
27.3
26.7
g/l
329.5
330.0
4.95
7129
50376
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
483
2296
1.61
20.16
1.4
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
442
5215
0.63
20.02
1.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
482
2296
1.60
19.95
1.4
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1038
10371
0.73
19.25
1.4
1.5
g/l
2.8
2.8
0.05
467
5582
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
6356
43761
1.18
18.80
5.1
6.4
mmol/l
1.2
1.2
14.08
5056
36265
(3044640) Blood type and Crossmatch panel - Blood
2898
25450
0.82
18.71
2.4
2.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
297
3765
0.59
18.11
1.8
1.8
g/l
1.6
1.5
0.15
227
3321
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
214
2948
0.54
17.65
2.9
3.9
u/ml
264.4
82.8
1.52
198
2801
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1169
11341
0.76
17.58
2.6
3.5
u/l
251.4
251.9
0.04
1003
10542
(3013139) Helicobacter pylori Ag [Presence] in Stool
356
4283
0.62
17.54
1.2
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
155
538
2.19
17.43
2.4
2.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
556
6037
0.68
16.79
3.0
2.9
ml/min/173m2
56.8
55.4
0.45
233
2855
(42870588) Differential panel, method unspecified - Blood
2958
25711
0.83
16.75
4.1
5.2
—
—
—
0
0
(3015736) pH of Urine
4342
29153
1.18
16.61
4.5
4.2
—
5.8
—
0
22
(3005719) IgG [Mass/volume] in Serum or Plasma
405
4672
0.64
16.54
2.5
2.6
g/l
10.7
10.8
0.09
329
4208
(40768443) Skin Pathology biopsy report
292
3623
0.60
16.36
1.2
1.2
—
—
—
0
0
(4094501)
91
1611
0.42
15.59
1.1
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
4120
27734
1.17
14.85
5.4
5.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
2328
14911
1.21
14.65
30.9
33.4
inr
1.7
1.6
1.85
158
1998
(3052592) Norovirus Ag [Presence] in Stool
79
220
2.72
14.31
1.4
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
9450
67878
1.17
14.26
20.6
19.6
mg/l
33.1
28.4
25.45
8132
57237
(3020779) Urea [Moles/volume] in Serum or Plasma
878
8619
0.75
14.22
4.0
5.7
mmol/l
12.0
12.3
0.46
787
8007
(3000494) Fungus identified in Specimen by Culture
778
7739
0.74
13.81
1.3
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
2730
17899
1.19
13.18
4.8
4.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
203
2603
0.58
13.01
1.4
1.6
u/l
37.1
38.2
0.29
146
2149
(3045414) Leukocytes [Presence] in Urine
286
3373
0.63
12.96
2.2
2.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1501
9294
1.25
12.95
2.5
2.5
ug/l
5.2
6.0
1.34
1067
7725
(3024891) Influenza virus A+B Ag [Presence] in Specimen
348
1706
1.55
12.87
1.3
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
189
789
1.82
12.81
3.5
3.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1172
7070
1.27
12.64
1.6
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
30
807
0.28
12.50
1.4
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1828
16233
0.82
12.39
2.9
3.5
ug/l
0.9
0.9
0.21
1292
12028
(3037467) Urinalysis macro (dipstick) panel - Urine
7393
52381
1.14
12.38
5.2
5.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
130
1865
0.52
12.38
1.9
2.7
u/ml
271.6
736.1
1.42
109
1695
(3019832) Treponema pallidum Ab [Presence] in Serum
255
1179
1.64
12.06
1.1
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1647
10393
1.22
11.84
10.6
9.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
90
1431
0.47
11.71
1.2
1.2
u/ml
4.4
5.1
0.17
13
245
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
217
2657
0.61
11.60
1.6
1.6
titre
112.5
244.8
2.14
16
136
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
78
1294
0.45
11.42
1.5
1.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1314
11970
0.81
11.41
3.5
4.9
mmol/l
1.0
1.0
0.37
1102
10816
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
1053
6348
1.27
11.40
1.9
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
90
1413
0.48
11.31
1.2
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
90
1412
0.48
11.29
1.2
1.2
u/ml
1.4
6.5
—
7
152
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
3626
24585
1.15
11.16
2.3
2.4
mg/l
3.1
3.2
2.26
2888
20652
(3015171) Extractable nuclear Ab [Units/volume] in Serum
162
2094
0.58
10.77
1.2
1.2
u/ml
0.5
1.0
0.69
16
208
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
645
3667
1.34
10.77
1.5
1.5
%
1.6
1.7
0.28
521
2907
(3005322) IgE [Units/volume] in Serum or Plasma
228
2711
0.63
10.77
1.2
1.2
u/ml
289.2
242.3
0.44
202
2446
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
175
2208
0.59
10.60
1.5
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
126
1730
0.54
10.44
1.6
1.6
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
104
1510
0.52
10.37
1.2
1.2
u/ml
3.6
44.7
—
5
78
(3048689) Calprotectin [Mass/mass] in Stool
617
6088
0.75
10.32
1.7
1.8
ug/g
176.6
176.3
0.00
434
4564
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
3929
32448
0.88
10.32
3.0
3.4
ng/l
2490.4
2176.0
2.71
3216
28410
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
118
459
1.95
10.03
1.1
1.1
—
3.3
—
0
10
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
96
348
2.09
9.90
1.0
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
78
1219
0.48
9.74
1.2
1.2
u/ml
1.1
6.6
—
7
97
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
120
1636
0.55
9.73
1.5
1.6
mg/l
13.2
12.6
0.28
98
1469
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
76
1194
0.48
9.64
1.1
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
192
879
1.66
9.54
1.2
1.2
nmol/l
315.5
305.8
0.24
146
643
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
131
1725
0.57
9.40
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
7836
56211
1.12
9.33
22.9
21.5
%
36.2
37.0
5.82
3990
31503
(3008152) Bicarbonate [Moles/volume] in Arterial blood
1017
6252
1.24
9.31
4.9
6.1
mmol/l
24.5
24.5
0.01
963
5821
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1325
11814
0.83
9.16
1.2
1.2
u/ml
1.7
1.7
0.06
281
2777
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
21
573
0.28
9.11
1.9
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
5207
36516
1.12
9.03
4.8
4.4
estimate
0.0
0.0
0.00
780
6941
(40768795) Lymph node Pathology biopsy report
33
707
0.35
8.97
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
302
3242
0.70
8.65
2.1
2.8
u/ml
406.1
2826.3
1.91
224
2745
(3045424) Erythrocytes [Presence] in Urine
83
1216
0.51
8.60
1.4
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1510
13216
0.84
8.43
2.2
2.6
%
19.7
20.6
1.65
1085
10996
(3042631) Mycobacterium sp identified in Specimen
111
1482
0.56
8.42
2.3
2.7
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
118
1549
0.57
8.42
2.5
2.1
%
210.8
215.0
0.20
107
1452
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
138
1737
0.59
8.38
1.4
1.4
g/l
1.1
1.1
0.12
125
1622
(4027681)
52
156
2.52
8.32
1.1
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
60
193
2.35
8.29
1.4
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
331
3464
0.71
8.19
2.6
2.7
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
67
228
2.22
8.15
3.0
2.8
umol/l
26.9
29.7
1.30
51
165
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
137
601
1.73
8.04
1.3
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
6639
47388
1.11
8.03
4.4
4.7
mmol/l
7.2
6.9
9.89
6197
44567
(3007566) Smooth muscle Ab [Titer] in Serum
110
1440
0.57
7.80
1.1
1.1
titre
70.0
136.5
—
8
95
(3004809) Band form neutrophils/100 leukocytes in Blood
126
1586
0.59
7.69
3.9
3.4
%
2.5
1.5
1.03
90
1189
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
95
1289
0.55
7.68
1.2
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
137
1688
0.61
7.66
1.4
1.4
g/l
0.2
0.2
0.12
124
1573
(3000330) Specific gravity of Urine by Test strip
534
5154
0.77
7.61
4.4
4.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
56
893
0.47
7.52
1.2
1.3
nmol/l
0.6
0.7
0.91
51
846
(40768800) Prostate Pathology biopsy report
155
1847
0.63
7.52
1.2
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1622
13990
0.86
7.50
2.1
2.5
g/l
2.2
2.2
5.16
1388
12688
(3017354) Segmented neutrophils/100 leukocytes in Blood
64
972
0.49
7.47
3.1
3.4
%
56.7
60.6
0.41
33
578
(3042936) Bacteria identified in Isolate by Culture
1343
11749
0.85
7.41
1.8
2.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
26
564
0.35
7.35
1.3
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
57
893
0.48
7.30
1.2
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
470
4582
0.76
7.25
1.4
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
5229
36987
1.11
7.23
4.9
4.5
estimate
0.0
0.0
1.08
760
6845
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
8995
70062
0.90
7.14
9.0
11.5
u/l
22.7
23.0
0.22
8248
66535
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
355
1967
1.37
7.13
1.2
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
47
782
0.45
7.12
1.1
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2627
17896
1.13
7.03
4.4
4.4
ng/l
253.5
429.1
1.90
2369
15997
(3042111) Morphology [Interpretation] in Bone marrow Narrative
132
1603
0.62
6.99
1.4
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
80
1108
0.54
6.99
3.8
3.6
iu/ml
225.6
2934.9
0.98
11
158
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
153
1796
0.64
6.97
1.8
2.1
g/l
3.6
3.6
0.17
141
1685
(4281824)
44
739
0.45
6.86
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
57
872
0.49
6.84
1.0
1.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
57
872
0.49
6.84
2.0
2.1
u/ml
80.3
992.4
1.51
57
855
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
261
2752
0.71
6.82
1.1
1.1
iu/ml
57.2
127.0
3.72
80
900
(3021601) Nitrite [Presence] in Urine by Test strip
5148
36472
1.10
6.75
6.2
6.0
estimate
0.0
0.0
0.50
752
6909
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
53
826
0.48
6.72
1.2
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
356
1993
1.36
6.72
1.2
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
138
1642
0.63
6.70
1.8
2.0
%
90.3
87.0
1.24
126
1549
(42529406) Shigella sp [Presence] in Stool by Culture
356
1995
1.35
6.68
1.2
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
52
810
0.48
6.59
1.2
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
217
0.17
6.48
1.0
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
459
4413
0.78
6.39
1.4
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
283
1546
1.39
6.25
1.5
2.0
umol/l
27.2
32.1
3.26
219
1216
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1600
13633
0.87
6.21
2.2
2.6
mmol/l
0.8
0.8
0.51
1366
12399
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
569
5307
0.80
6.13
2.4
2.6
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
55
819
0.50
6.13
1.5
1.5
g/l
0.8
0.8
0.07
43
613
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
65
247
1.99
6.08
1.1
1.1
mg/l
40.2
46.2
0.57
53
207
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
98
426
1.74
6.06
1.1
1.2
mmol/l
2.0
2.2
2.18
90
385
(3034860) Kappa light chains.free [Mass/volume] in Serum
371
3635
0.76
6.00
2.6
2.8
mg/l
55.0
89.3
1.19
285
2953
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
370
3626
0.76
5.99
2.6
2.8
mg/l
48.8
54.9
0.30
288
2942
(3039000) Anion gap in Blood
353
2017
1.33
5.87
4.4
5.8
mmol/l
11.4
11.3
0.12
322
1800
(3018572) Chloride [Moles/volume] in Blood
353
2017
1.33
5.87
4.5
5.8
mmol/l
104.6
104.9
0.42
322
1800
(3043409) Potassium [Moles/volume] in Arterial blood
498
2986
1.27
5.76
3.0
3.9
mmol/l
3.9
3.9
0.45
441
2766
(3044889) 12 lead EKG panel
6335
49936
0.92
5.69
4.6
4.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
270
2740
0.74
5.62
1.2
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
485
4557
0.79
5.61
3.2
3.3
e9/l
4.6
4.3
0.75
286
3044
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
75
988
0.57
5.58
1.2
1.2
u/ml
87.2
46.8
—
7
112
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1875
15700
0.88
5.54
1.5
1.7
mg/l
1.9
1.6
1.66
1413
12394
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
539
4998
0.80
5.54
4.3
7.0
mmol/l
24.1
24.4
0.67
471
4544
(3023419) Bacteria identified in Sputum by Culture
94
1164
0.61
5.50
1.7
2.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1375
9113
1.15
5.48
4.6
4.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
70
284
1.86
5.46
1.1
1.1
nmol/l
132.4
134.9
0.14
70
284
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
29
520
0.42
5.44
1.2
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
170
1852
0.69
5.44
2.6
2.5
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
79
334
1.79
5.41
1.2
1.2
promille
0.7
0.9
1.03
62
245
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
124
1435
0.65
5.39
2.6
3.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
437
4133
0.79
5.36
1.9
2.2
g/l
3.9
3.8
0.47
263
2818
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
103
1240
0.62
5.36
1.5
1.7
ug/l
18.1
24.0
1.46
98
1200
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
36
587
0.46
5.29
3.1
3.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
440
4149
0.79
5.27
1.9
2.2
g/l
7.7
7.6
0.51
270
2923
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
225
2322
0.73
5.25
1.3
1.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
166
1803
0.69
5.24
2.4
2.4
mg/l
1.8
1.9
0.57
129
1563
(3017446) Testosterone [Moles/volume] in Serum or Plasma
384
3675
0.78
5.22
1.9
2.0
nmol/l
9.5
10.2
0.94
306
3027
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
440
4143
0.79
5.21
1.9
2.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
366
3521
0.78
5.19
2.6
2.8
ratio
3.7
2.7
0.38
24
258
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
254
2565
0.74
5.15
1.6
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
56
780
0.54
5.11
1.2
1.3
nmol/l
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
63
844
0.56
5.03
1.7
2.0
u/ml
679.2
1924.3
—
5
66
(3022313) Gas panel - Capillary blood
463
4312
0.80
4.98
3.1
3.9
—
—
—
0
0
(3036603) Volume of Urine
29
499
0.44
4.94
2.6
1.5
ml
1719.5
1804.6
0.13
14
161
(3020630) Protein [Mass/volume] in Serum or Plasma
995
8632
0.86
4.93
2.0
2.4
g/l
65.1
65.7
1.32
789
7593
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
414
3899
0.79
4.93
1.8
2.2
g/l
10.5
10.4
0.19
294
3167
(4024509)
74
942
0.59
4.89
1.4
1.7
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
62
827
0.56
4.89
1.1
1.3
mu/l
30.0
54.7
1.44
51
717
(3005988) Vibrio sp identified in Specimen by Organism specific culture
87
1062
0.61
4.85
1.2
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
88
1069
0.62
4.81
1.2
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
90
1087
0.62
4.80
1.2
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
87
1059
0.62
4.80
1.2
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
1804
15015
0.89
4.79
2.1
2.5
umol/l
10.6
11.4
4.89
1525
13627
(3025468) Yersinia sp identified in Specimen by Organism specific culture
87
1058
0.62
4.78
1.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
376
2233
1.28
4.77
1.2
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
87
1057
0.62
4.76
1.2
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
6770
53001
0.92
4.76
3.7
4.4
mm/h
16.8
16.2
1.75
5844
47899
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
45
654
0.52
4.75
1.5
1.7
mg/l
4.4
5.0
0.44
37
611
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
404
3797
0.80
4.74
1.9
2.2
g/l
3.2
3.1
0.49
265
2872
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
256
2548
0.75
4.73
1.9
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
20
392
0.38
4.69
1.0
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
523
3239
1.23
4.61
1.9
2.2
ug/l
1126.9
571.8
0.72
477
3063
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
67
860
0.59
4.60
1.2
1.2
—
16.2
—
0
12
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
57
230
1.87
4.58
1.0
1.1
mg/l
294.3
321.8
0.40
47
200
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
203
2079
0.73
4.57
1.9
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
14
319
0.33
4.54
1.2
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
459
2812
1.24
4.49
4.4
5.3
mmol/l
1.4
1.4
0.62
409
2486
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
88
1050
0.63
4.48
1.4
1.5
%
74.2
64.8
2.02
58
663
(21494890) Protein electrophoresis panel - 24 hour Urine
89
1057
0.63
4.44
2.0
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
9
223
0.30
4.43
4.2
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
162
1711
0.71
4.43
1.4
1.5
iu/ml
57.5
5.7
1.07
57
462
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
58
239
1.83
4.39
1.2
1.5
umol/l
75.9
100.9
0.63
33
143
(3018095) Leukocytes [#/volume] in Urine
4172
29719
1.08
4.33
4.2
4.1
e6/l
208.6
145.0
1.47
3039
22062
(3019225) pH of Specimen
1075
9181
0.87
4.30
4.3
4.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
62
795
0.59
4.27
1.1
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
33
510
0.49
4.25
1.9
2.2
ug/min
40.1
93.6
—
7
122
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
91
1063
0.64
4.23
3.1
3.5
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
56
232
1.82
4.18
2.5
2.0
umol/l
56.9
56.6
0.02
40
168
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
92
1069
0.65
4.18
1.5
1.4
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
29
94
2.33
4.11
1.1
1.2
%
20.8
49.4
—
10
34
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
137
1459
0.70
3.98
1.3
1.3
u/l
47.9
40.3
0.25
112
1241
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
135
706
1.45
3.97
1.3
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
81
954
0.64
3.94
1.2
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
34
505
0.51
3.92
3.0
1.7
e9/l
1.0
1.0
0.02
24
324
(40761511) CBC panel - Blood by Automated count
9206
67732
1.08
3.91
19.8
19.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
61
766
0.60
3.91
1.1
1.2
pmol/l
229.4
255.6
0.48
45
573
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
93
1060
0.66
3.89
2.7
3.6
u/ml
34.5
43.7
0.51
84
1028
(3035637) Corticotropin [Mass/volume] in Plasma
56
717
0.59
3.88
1.1
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
73
875
0.63
3.85
1.2
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
67
818
0.62
3.83
1.0
1.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
709
6178
0.86
3.77
2.9
3.7
kpa
5.2
5.2
0.51
613
5612
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
25
79
2.39
3.77
2.2
2.4
nmol/l
148.2
136.1
0.30
19
68
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
205
0.33
3.75
4.2
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
700
6102
0.86
3.75
2.9
3.7
ph
7.4
7.4
0.78
99
804
(3028707) Methadone [Presence] in Urine by Screen method
26
84
2.34
3.74
1.1
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
132
697
1.43
3.71
1.3
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
58
727
0.60
3.71
1.1
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
844
7251
0.87
3.71
2.1
2.3
—
—
—
0
0
(4015189)
12
261
0.35
3.62
1.8
2.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
124
1319
0.71
3.61
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
287
2709
0.79
3.59
2.7
2.9
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
0
70
0.00
3.57
0.0
1.2
—
80.6
—
0
7
(3021788) Differential panel - Synovial fluid
148
1522
0.73
3.52
1.4
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
256
0.35
3.49
1.8
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
105
1142
0.69
3.49
1.2
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
5253
41218
0.93
3.47
3.9
5.7
umol/l
12.9
12.6
0.77
4723
38904
(3020650) Glucose [Presence] in Urine
5
147
0.26
3.45
1.2
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
9652
71261
1.08
3.44
24.5
23.9
mmol/l
139.7
139.4
13.91
9185
69215
(3001019) Free T4 and TSH panel - Serum or Plasma
45
589
0.57
3.44
1.5
1.7
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
187
1851
0.76
3.43
1.4
1.5
g/l
29.9
30.7
0.45
166
1636
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
19
329
0.43
3.41
1.1
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
19
329
0.43
3.41
1.1
1.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
9659
71324
1.08
3.41
24.5
24.1
mmol/l
4.0
4.0
1.84
9168
69166
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2510
20232
0.92
3.41
2.5
3.0
u/l
36.1
37.3
0.29
2269
18872
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
14
275
0.38
3.41
1.0
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
72
837
0.65
3.36
1.1
1.2
u/l
54.9
60.5
0.38
45
561
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
29
429
0.51
3.36
1.1
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
29
429
0.51
3.36
1.1
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
29
429
0.51
3.36
1.1
1.5
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
544
3495
1.18
3.34
3.0
3.6
mmol/l
1.5
1.4
0.78
535
3425
(3025130) Human papilloma virus identified in Specimen
16
294
0.41
3.34
2.1
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
36
497
0.54
3.34
1.1
1.0
—
—
—
0
0
(4146454)
89
989
0.68
3.33
2.4
2.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
594
5189
0.86
3.30
1.5
1.6
g/l
1.6
1.6
0.54
447
4392
(3047189) Immunofixation for 24 hour Urine
32
453
0.53
3.24
1.1
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
3711
26559
1.07
3.23
3.7
3.6
e6/l
118.6
122.1
0.04
2893
20834
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
34
131
1.96
3.22
3.5
3.0
u/field
0.4
0.5
0.36
34
131
(3048929) Epstein Barr virus Ab [Presence] in Serum
80
899
0.67
3.19
1.1
1.1
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
38
508
0.56
3.17
1.2
1.3
g/l
2.7
2.9
0.38
26
361
(3027135) IgG subclass 1 [Mass/volume] in Serum
38
508
0.56
3.17
1.2
1.3
g/l
6.8
7.1
0.25
27
356
(3024139) IgG subclass 3 [Mass/volume] in Serum
38
508
0.56
3.17
1.2
1.3
g/l
0.5
0.5
0.01
27
361
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
42
546
0.58
3.16
1.3
1.2
mmol/l
7.3
8.2
1.31
32
338
(3009214) Lutropin [Units/volume] in Serum or Plasma
51
630
0.61
3.14
1.3
1.3
u/l
14.4
13.3
0.18
35
491
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
181
1773
0.77
3.11
1.2
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
46
581
0.60
3.10
1.2
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
71
811
0.66
3.08
1.4
1.5
%
15.4
26.4
4.25
48
506
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
383
3448
0.83
3.07
1.8
2.3
g/l
1.4
1.2
0.28
274
2837
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
686
5893
0.87
3.06
2.9
3.7
mmol/l
2.0
2.1
0.21
483
4306
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
21
333
0.47
3.02
1.2
1.6
—
—
—
0
0
(4062490)
39
510
0.58
3.02
1.3
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
998
6748
1.12
3.01
3.5
4.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
113
1179
0.72
3.00
1.3
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
24
362
0.50
2.99
1.0
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
39
508
0.58
2.98
1.0
1.1
%
119.3
113.7
0.63
30
433
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
325
2960
0.82
2.96
1.8
2.2
g/l
0.0
0.0
1.08
254
2653
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
30
420
0.54
2.96
1.1
1.1
u/l
115.9
91.1
0.58
21
306
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
49
219
1.69
2.94
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
118
1218
0.73
2.94
1.2
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
60
702
0.64
2.94
1.1
1.1
iu/ml
100.2
428.8
—
10
106
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
30
419
0.54
2.94
1.1
1.1
u/l
60.3
31.2
0.76
18
296
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
11
223
0.37
2.92
1.5
2.6
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
28
398
0.53
2.91
1.1
1.4
%
4.0
3.4
—
8
89
(3037121) Protein [Mass/volume] in Urine
343
3101
0.83
2.90
2.4
2.7
g/l
0.3
0.3
0.10
110
1177
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
31
427
0.55
2.90
1.1
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
12
232
0.39
2.87
1.3
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
89
958
0.70
2.86
1.1
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
22
336
0.49
2.86
1.0
1.0
mg/l
285.4
294.5
0.23
16
292
(3010813) Leukocytes [#/volume] in Blood
9709
71852
1.07
2.86
28.4
28.9
e9/l
7.4
7.1
8.55
9122
68997
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
65
742
0.66
2.85
1.2
1.2
u/ml
116.7
118.1
0.05
17
175
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
61
705
0.65
2.84
1.2
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
61
705
0.65
2.84
1.2
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
61
705
0.65
2.84
1.2
1.4
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
115
1183
0.73
2.82
1.3
1.4
mmol/l
6.3
6.4
0.16
97
1107
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
399
3549
0.84
2.82
3.3
4.2
mmol/l
25.0
24.9
0.34
325
3164
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
17
283
0.45
2.82
1.8
2.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
61
704
0.65
2.82
1.1
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
142
1415
0.75
2.81
1.4
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
931
7798
0.89
2.79
3.6
6.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
58
675
0.65
2.79
1.1
1.1
u/ml
273.1
300.4
0.32
39
386
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
350
3143
0.83
2.77
1.2
1.3
au/ml
50.0
54.5
0.10
14
128
(44813793)
18
291
0.47
2.76
1.0
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
208
1239
1.27
2.75
11.8
14.6
mmol/l
8.0
7.4
1.17
164
1010
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
244
2264
0.81
2.71
2.0
2.2
ug/min
84.8
99.2
0.26
121
1253
(3035941) MCH [Entitic mass]
9701
71835
1.07
2.70
28.3
28.7
pg
30.3
30.4
3.25
9267
70173
(3049717) Cytology report of Urine Cyto stain
499
4341
0.86
2.69
2.7
2.9
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
60
687
0.66
2.69
9.2
12.9
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
9701
71839
1.07
2.69
28.4
28.9
e12/l
4.2
4.3
46.09
9104
68958
(3008757) Leukocyte morphology finding [Identifier] in Blood
98
1025
0.72
2.69
5.1
3.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
2930
23283
0.93
2.68
4.4
5.0
%
21.5
22.6
3.66
1437
13019
(3004775) Volume in Urine collected for unspecified duration
72
794
0.68
2.67
2.1
2.1
ml
675.0
645.3
0.21
36
487
(3007461) Platelets [#/volume] in Blood
9699
71831
1.07
2.66
28.4
28.8
e9/l
235.9
236.0
0.07
9158
69303
(3024731) MCV [Entitic volume]
9700
71839
1.07
2.66
28.3
28.8
fl
91.9
92.0
1.39
9270
70178
(3000963) Hemoglobin [Mass/volume] in Blood
9701
71849
1.07
2.65
28.6
29.1
g/l
126.7
129.6
63.93
9249
70203
(3024354) Oxygen [Partial pressure] in Venous blood
1139
7821
1.11
2.63
2.4
3.1
kpa
4.1
4.3
3.37
1077
7520
(3000475) Leukocytes [#/volume] in Synovial fluid
217
2031
0.80
2.62
1.5
1.6
e6/l
24777.0
14932.5
1.01
152
1451
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
40
498
0.60
2.61
1.2
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
40
498
0.60
2.61
1.2
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
3206
22980
1.07
2.61
3.5
3.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
126
0.30
2.60
13.8
12.8
mmol/l
5.7
5.5
—
5
126
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
31
412
0.57
2.60
1.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
65
323
1.52
2.59
1.1
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
300
2713
0.83
2.59
1.8
2.2
g/l
0.0
0.0
0.00
240
2460
(3012441) Differential panel - Pleural fluid
141
1388
0.76
2.59
1.4
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
17
273
0.47
2.59
1.9
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
63
311
1.53
2.58
1.1
1.1
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
8
162
0.37
2.58
1.0
1.0
—
1.8
—
0
14
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
149
0.35
2.58
4.6
1.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
28
382
0.55
2.58
2.6
1.7
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
6
140
0.32
2.57
1.0
1.3
—
1.5
—
0
20
(3012565) Volume of 24 hour Urine
26
362
0.54
2.56
1.8
2.3
ml
1627.1
1783.6
0.28
17
298
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
85
901
0.71
2.55
1.6
1.5
mg/l
2.2
2.9
0.63
66
685
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
124
1239
0.75
2.54
1.3
1.3
u/l
407.3
397.4
0.05
109
1170
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
31
127
1.84
2.52
2.3
2.1
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
680
5763
0.88
2.52
4.3
7.1
%
92.5
93.6
2.92
674
5738
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
28
379
0.56
2.51
2.5
1.7
%
16.6
15.6
0.12
17
143
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
435
3800
0.86
2.50
2.1
2.5
u/ml
0.4
0.3
0.77
248
2171
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
31
407
0.57
2.50
1.1
1.2
mmol/l
12.7
12.3
—
8
127
(3023520) Reticulocytes [#/volume] in Blood
1129
9299
0.91
2.49
2.2
2.4
e9/l
65.2
66.9
0.84
846
7099
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
4807
37544
0.94
2.48
2.8
3.1
u/l
52.4
57.5
2.71
4096
33460
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
263
2397
0.82
2.48
1.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
122
0.31
2.46
9.0
8.5
—
—
—
0
0
(4198724)
13
37
2.65
2.46
1.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
23
326
0.53
2.43
1.0
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
63
316
1.50
2.42
1.7
2.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
63
316
1.50
2.42
1.7
2.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
44
524
0.63
2.40
2.5
1.9
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
22
315
0.53
2.40
1.2
1.1
u/ml
0.4
0.9
—
7
108
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
309
2763
0.84
2.38
1.8
2.2
g/l
0.0
0.0
0.26
240
2471
(4306422)
44
521
0.64
2.35
1.2
1.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
31
399
0.58
2.34
1.0
1.1
%
96.4
90.1
0.90
24
359
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
76
807
0.71
2.33
1.3
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
585
4976
0.88
2.32
1.3
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
6868
50460
1.05
2.31
3.6
4.0
pmol/l
15.2
15.3
0.99
5820
44126
(3039443) Prostate specific Ag panel - Serum or Plasma
48
555
0.65
2.31
1.6
1.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
267
2411
0.83
2.31
2.3
2.9
kpa
7.4
7.7
2.19
255
2225
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
24
330
0.55
2.30
6.9
5.1
%
48.9
73.0
1.93
17
258
(3016750) Collection duration of Urine
46
536
0.65
2.29
2.2
1.9
min
496.4
501.0
0.09
30
366
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
46
0.00
2.29
0.0
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
363
3189
0.85
2.28
1.7
2.1
g/l
36.1
36.6
0.76
252
2611
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
27
357
0.57
2.26
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
27
356
0.57
2.24
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
27
356
0.57
2.24
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
27
356
0.57
2.24
1.1
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
4864
37897
0.95
2.24
11.2
12.3
inr
1.4
1.4
2.97
1175
10153
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
30
127
1.78
2.24
2.4
2.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
132
1282
0.77
2.24
1.3
1.3
—
—
—
0
0
(4268621)
28
365
0.58
2.23
2.0
2.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1406
9832
1.09
2.23
3.5
3.2
ng/l
280.0
290.3
0.30
1283
9034
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
152
1450
0.79
2.23
2.4
3.4
%
61.4
59.7
0.84
152
1450
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
27
355
0.57
2.22
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
27
355
0.57
2.22
1.1
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
116
1144
0.76
2.21
1.2
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
51
250
1.54
2.21
1.6
1.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
18
266
0.51
2.20
2.1
1.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
144
1379
0.78
2.19
1.4
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
8320
61485
1.05
2.18
4.8
5.0
mu/l
2.0
2.1
2.43
7203
54145
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
43
502
0.64
2.18
1.5
1.7
pmol/l
163.1
188.8
1.34
36
447
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
18
64
2.12
2.17
1.1
1.1
pmol/l
24.0
14.0
0.95
18
56
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
41
483
0.64
2.17
1.1
1.2
titre
100.0
133.7
—
6
91
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
25
333
0.56
2.17
2.4
1.8
e6/l
413.0
538.4
—
5
141
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
54
600
0.68
2.15
1.1
1.2
u/ml
1.6
3.8
1.97
14
183
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
51
573
0.67
2.15
1.1
1.2
u/ml
5.8
4.3
0.26
17
257
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
67
715
0.70
2.15
1.1
1.1
u/ml
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
487
4166
0.88
2.13
1.2
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
63
326
1.46
2.13
1.2
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
63
678
0.70
2.12
1.1
1.2
—
—
—
0
0
(44806420)
33
406
0.61
2.11
2.0
2.5
—
—
—
0
0
(3036489) Thrombin time
262
2348
0.84
2.11
1.7
1.8
s
21.6
22.1
0.30
236
2141
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
39
461
0.64
2.10
1.0
1.1
u/ml
1.0
4.6
—
7
86
(3028717) Thiamine [Mass/volume] in Blood
16
55
2.19
2.10
1.1
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
13
210
0.47
2.07
1.2
1.5
ug/l
7.5
10.9
1.12
13
188
(3017817) Protein [Mass] in Urine collected for unspecified duration
78
806
0.73
2.07
2.1
1.9
—
0.4
—
0
7
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
43
495
0.65
2.06
1.6
1.5
u/l
4.7
6.8
0.58
20
225
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
12
199
0.45
2.05
2.9
2.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
20
279
0.54
2.05
2.0
1.8
u/ml
870.5
1649.6
2.91
20
269
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
119
1156
0.77
2.05
1.2
1.3
nmol/l
0.9
0.8
0.43
94
928
(3014576) Chloride [Moles/volume] in Serum or Plasma
1458
11768
0.93
2.05
4.0
5.8
mmol/l
104.5
104.2
1.54
1387
11469
(4133840)
5
113
0.33
2.04
1.6
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
12
198
0.46
2.03
1.3
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
14
46
2.30
2.03
1.0
1.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
60
644
0.70
2.01
1.7
1.8
ug/l
2.5
4.3
1.72
55
555
(1002224) Polysomnography panel
93
931
0.75
2.01
1.0
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
9
154
0.44
1.99
4.2
2.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
11
186
0.45
1.99
4.7
1.6
%
206.4
183.8
0.22
11
165
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
187
1149
1.23
1.99
1.8
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
171
1586
0.81
1.99
1.5
1.6
—
—
—
0
0
(3004451) EKG impression Narrative
50
553
0.68
1.98
1.3
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
69
719
0.72
1.95
1.3
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
39
0.00
1.92
0.0
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
23
301
0.58
1.91
2.1
2.5
%
37.1
36.8
—
8
115
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
42
0.00
1.89
0.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
110
1065
0.78
1.88
1.1
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
47
236
1.50
1.87
1.2
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
48
528
0.68
1.86
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
72
738
0.73
1.85
1.2
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
24
307
0.59
1.84
1.0
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
3737
29191
0.95
1.83
4.5
5.8
ug/l
7.1
5.1
0.59
3077
25439
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
19
258
0.55
1.81
2.8
2.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
27
119
1.71
1.81
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
18
248
0.55
1.81
1.2
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1971
14073
1.07
1.80
3.2
3.3
e6/l
2.8
2.8
0.05
1102
8053
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
62
647
0.72
1.79
1.2
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
69
707
0.73
1.78
1.2
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
71
391
1.37
1.76
1.1
1.3
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
314
2725
0.87
1.75
3.3
3.7
mmol/l
1.8
1.7
1.50
308
2674
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
74
748
0.74
1.75
1.2
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
176
1603
0.83
1.75
1.4
1.5
e6/l
3346.2
1992.6
0.57
131
1162
(3008116) Ketones [Moles/volume] in Urine by Test strip
33
156
1.60
1.72
1.2
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
38
0.00
1.72
0.0
1.1
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
41
456
0.68
1.71
1.3
1.4
%
3.6
2.5
0.33
28
374
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
44
482
0.69
1.70
1.1
1.2
u/l
105.3
95.2
0.22
36
416
(3051387) C reactive protein [Mass/volume] in Capillary blood
307
2006
1.16
1.69
4.1
4.0
mg/l
35.2
30.5
1.19
231
1374
(3020891) Body temperature
567
3855
1.11
1.68
3.5
4.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
2421
19084
0.95
1.67
3.4
4.0
%
78.8
80.8
3.02
2332
18628
(3028308) Erythrocytes [#/volume] in Pleural fluid
161
1471
0.82
1.67
1.4
1.5
e6/l
44528.1
62567.5
0.64
99
875
(3000850) Epithelial cells [#/volume] in Urine
2641
19064
1.06
1.67
2.9
2.8
e6/l
5.8
5.0
2.47
2326
16690
(3003888) Timothy IgE Ab [Units/volume] in Serum
21
270
0.59
1.67
1.0
1.0
u/ml
1.8
1.5
—
7
106
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
49
524
0.70
1.66
1.3
1.4
%
62.2
67.8
0.46
35
417
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
22
279
0.59
1.66
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
22
279
0.59
1.66
1.0
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
13
192
0.51
1.65
1.5
1.3
umol/l
27.8
30.5
0.91
13
184
(3006442) Creatine [Moles/volume] in Serum or Plasma
42
458
0.69
1.60
2.3
1.8
—
71.8
—
0
16
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
102
973
0.79
1.59
1.2
1.3
u/l
25.9
12.1
1.57
88
888
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
418
3531
0.89
1.58
2.1
2.5
au/ml
49.1
29.5
—
6
72
(3030313) Adrenal Ab [Titer] in Serum
7
19
2.78
1.58
1.0
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
26
312
0.63
1.58
1.6
1.5
u/l
5.2
6.3
0.81
21
251
(1761482) Bacteria [#/volume] in Urine by Culture
374
3180
0.88
1.57
4.9
5.1
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
32
0.00
1.55
0.0
13.2
—
215.9
—
0
26
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
27
320
0.64
1.55
2.5
1.8
e6/l
528.2
479.2
0.18
22
278
(40758358) Immune stain study
0
34
0.00
1.54
0.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
10
157
0.48
1.54
1.0
1.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
11
167
0.50
1.54
1.2
1.5
ng/l
137.9
132.0
0.06
11
167
(3022689) Creatine [Moles/volume] in Urine
12
176
0.51
1.51
1.3
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
21
262
0.60
1.51
1.0
1.0
u/ml
0.5
1.3
—
6
97
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
32
156
1.55
1.50
1.0
1.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
1159
8184
1.07
1.50
3.2
5.3
mmol/l
1.6
1.4
5.68
1094
7774
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
92
878
0.79
1.47
1.2
1.4
u/l
14.1
13.7
0.24
86
836
(3001122) Ferritin [Mass/volume] in Serum or Plasma
3887
30193
0.96
1.46
2.6
3.0
ug/l
146.1
157.6
1.84
3288
26803
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
189
1677
0.85
1.46
1.5
1.5
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
7
118
0.45
1.45
1.0
1.2
—
13.5
—
0
6
(3045788) Cell count panel - Pleural fluid
134
1225
0.82
1.44
1.5
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
14
192
0.55
1.43
1.2
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
162
1454
0.84
1.43
1.3
1.5
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
146
911
1.21
1.43
2.0
1.6
u/ml
28.7
26.4
0.26
41
188
(3000034) Microalbumin [Mass/volume] in Urine
81
782
0.78
1.43
2.3
3.0
mg/l
37.8
33.3
0.14
52
595
(3021901) Oxygen saturation in Capillary blood
241
2093
0.87
1.42
2.4
2.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
78
756
0.78
1.42
1.1
1.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
106
0.43
1.42
1.2
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
53
542
0.74
1.42
1.1
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
92
0.41
1.40
1.0
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
2532
18344
1.05
1.39
3.0
3.0
mosm/kgh2o
564.8
539.9
8.37
2116
15556
(3015235) Bicarbonate [Moles/volume] in Capillary blood
320
2722
0.88
1.39
2.6
3.1
mmol/l
25.0
25.0
0.05
290
2378
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
28
320
0.66
1.39
1.1
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
95
0.40
1.39
9.2
7.8
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
85
811
0.79
1.37
1.2
1.4
e6/l
146186.5
194438.4
0.23
54
560
(3003396) Base excess in Arterial blood by calculation
1558
11148
1.06
1.37
3.9
5.7
mmol/l
1.3
1.2
0.62
1148
8506
(3047007) Chlamydophila sp Ab [Presence] in Serum
47
486
0.73
1.36
1.4
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
128
1167
0.82
1.36
1.3
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
55
555
0.75
1.36
3.1
2.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
28
318
0.66
1.36
1.1
1.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
63
623
0.76
1.35
1.8
1.9
ug/l
1.6
2.2
1.09
51
521
(40765089) Chromosome analysis panel - Blood by G-banded
6
17
2.66
1.35
1.2
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
28
137
1.54
1.32
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
18
224
0.61
1.31
1.1
1.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
45
465
0.73
1.31
1.1
1.2
u/l
34.5
29.5
0.24
34
394
(3003129) Base excess in Capillary blood by calculation
19
233
0.61
1.31
1.5
1.9
mmol/l
1.2
0.8
0.16
14
216
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
101
0.45
1.30
1.0
1.0
—
—
—
0
0
(4034850)
349
2352
1.12
1.28
12.9
13.9
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
15
62
1.82
1.28
1.1
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
214
1856
0.87
1.27
1.3
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
40
419
0.72
1.27
4.9
4.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
123
0.49
1.26
1.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
54
539
0.75
1.26
1.2
1.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
41
220
1.41
1.25
1.4
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
55
547
0.76
1.25
1.2
1.5
%
9.6
10.2
0.35
55
547
(3020393) Adenovirus Ag [Presence] in Stool
17
74
1.73
1.25
1.1
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
54
538
0.76
1.24
1.2
1.5
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
21
246
0.64
1.20
1.6
1.7
e6/l
5261.5
19767.0
1.04
13
142
(3016038) Potassium [Moles/volume] in Urine
108
668
1.22
1.20
1.1
1.1
mmol/l
36.9
34.4
0.53
81
554
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
130
0.52
1.20
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
28
141
1.50
1.19
1.1
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
24
272
0.66
1.18
1.6
1.9
e6/l
615.4
6023.3
0.96
15
189
(3022229) Phosphate [Moles/volume] in Urine
0
26
0.00
1.18
0.0
1.1
—
16.0
—
0
15
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
11
151
0.55
1.17
7.0
8.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
724
5855
0.93
1.17
4.1
6.9
%
1.5
1.3
5.84
717
5802
(40758558) Short blood count panel - Blood
2328
18192
0.96
1.15
5.0
6.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
14
59
1.79
1.14
1.1
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
20
94
1.60
1.13
1.4
1.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
19
224
0.64
1.13
1.2
1.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
722
5830
0.93
1.13
4.1
7.0
%
0.7
0.7
4.04
713
5777
(3036670) Protein [Mass/volume] in Synovial fluid
29
313
0.70
1.12
1.1
1.2
g/l
40.7
40.2
0.09
18
153
(3027008) Opiates [Presence] in Urine
28
143
1.48
1.12
1.1
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
624
4363
1.08
1.12
2.4
3.6
mmol/l
24.1
24.1
0.19
561
3884
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
13
54
1.82
1.11
1.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
13
54
1.82
1.11
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
13
54
1.82
1.11
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
595
4834
0.92
1.10
5.0
7.8
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
10
138
0.55
1.10
4.3
1.6
%
231.4
219.4
—
10
124
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
10
138
0.55
1.10
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
28
144
1.47
1.09
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
166
0.59
1.08
1.3
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
55
534
0.78
1.08
1.1
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
129
823
1.18
1.07
1.3
1.3
mosm/kgh2o
277.0
274.4
0.48
86
579
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
232
1972
0.88
1.07
1.3
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
25
274
0.69
1.06
1.1
1.3
umol/l
5.4
13.8
2.29
16
181
(3016879) Cocaine [Presence] in Urine
27
139
1.46
1.05
1.1
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
459
3179
1.09
1.04
3.6
3.3
nmol/l
0.8
0.8
0.81
351
2471
(3035880) pH of Pleural fluid
79
731
0.81
1.04
1.1
1.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
44
437
0.76
1.03
1.5
1.9
mmol/l
8.8
9.1
0.19
31
337
(3014148) Varicella zoster virus Ab [Titer] in Serum
26
281
0.70
1.03
1.1
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
81
0.47
1.03
1.4
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
19
218
0.66
1.02
5.3
5.7
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
30
159
1.42
1.02
1.1
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
16
190
0.63
1.01
1.3
1.3
u/l
55.7
39.5
—
9
150
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
59
561
0.79
1.00
1.1
1.2
nmol/l
1.0
1.5
4.21
53
503
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
22
0.00
0.99
0.0
2.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
9
122
0.56
0.99
1.1
1.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
25
0.00
0.96
0.0
2.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
25
0.00
0.96
0.0
1.4
—
313.2
—
0
25
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
132
0.57
0.96
1.1
1.1
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
6
89
0.51
0.96
2.8
1.4
pmol/l
69.0
48.7
—
6
69
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1235
8885
1.05
0.95
4.1
6.3
g/l
119.8
118.4
1.56
1185
8558
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
634
5100
0.93
0.93
3.7
5.8
mmol/l
24.7
24.8
0.31
623
5028
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
34
188
1.36
0.93
1.1
1.1
u/l
1.0
1.2
2.69
19
101
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
31
318
0.73
0.93
1.1
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
79
0.48
0.90
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
30
164
1.38
0.89
1.1
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
12
147
0.61
0.88
2.9
2.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
84
527
1.20
0.88
1.8
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
16
183
0.66
0.88
1.1
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
10
128
0.59
0.87
1.0
1.4
—
—
—
0
0
(4211845)
47
450
0.79
0.87
4.7
4.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
51
482
0.80
0.85
1.1
1.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1536
11144
1.04
0.85
3.9
5.7
kpa
4.9
5.0
5.11
1436
10476
(3027801) Oxygen [Partial pressure] in Arterial blood
1535
11137
1.04
0.85
3.9
5.7
kpa
11.2
11.6
2.59
1434
10463
(3000570) Elastase.pancreatic [Mass/mass] in Stool
275
2278
0.91
0.85
1.3
1.4
ug/g
259.4
261.3
0.05
137
1418
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
38
372
0.77
0.85
1.0
1.1
nmol/l
2.5
12.3
—
6
91
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
19
208
0.69
0.84
1.4
1.5
ug/l
0.4
0.4
—
6
108
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
87
0.52
0.84
1.0
2.3
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
20
216
0.70
0.83
1.8
1.6
ug/l
132.3
114.5
0.21
15
182
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
151
1292
0.88
0.83
2.0
2.2
mg/l
35.5
29.3
0.48
37
306
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
46
438
0.79
0.83
1.3
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
153
0.64
0.82
1.1
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
82
518
1.19
0.81
2.5
2.1
u/field
1.5
2.4
1.01
57
337
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
30
167
1.35
0.81
1.1
1.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.81
0.0
5.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
155
1320
0.88
0.80
1.5
1.5
iu/l
3.1
4.3
1.38
43
365
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
524
4213
0.93
0.79
2.0
2.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
978
7714
0.95
0.77
3.3
3.8
mmol/l
1.2
1.2
0.24
754
6668
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
22
229
0.72
0.76
1.5
1.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
40
1.70
0.75
2.0
1.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
10
122
0.62
0.75
1.1
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
114
748
1.15
0.74
1.3
1.3
titre
275.0
326.7
0.15
20
81
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
143
954
1.13
0.73
2.5
2.4
u/field
2.4
2.3
0.10
57
303
(3023323) Follitropin [Units/volume] in Serum or Plasma
31
304
0.77
0.73
1.4
1.4
iu/l
63.7
35.2
3.28
26
256
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
87
764
0.86
0.72
1.1
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
14
69
1.53
0.71
1.0
1.1
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
11
129
0.64
0.70
1.1
1.2
u/l
15.4
17.5
—
5
87
(3010421) pH of Blood
362
2537
1.08
0.70
3.6
4.3
ph
7.4
7.4
0.77
299
2163
(3027944) Amphetamines [Presence] in Urine
25
140
1.35
0.68
1.1
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
5
72
0.52
0.67
1.0
1.1
—
0.4
—
0
24
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21
215
0.74
0.67
1.3
1.3
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
7
32
1.65
0.67
1.4
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
17
180
0.71
0.67
1.6
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
127
0.65
0.66
1.0
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
771
5545
1.05
0.66
4.2
3.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
283
2307
0.92
0.66
3.2
3.8
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
1367
9959
1.04
0.66
4.0
5.9
%
94.8
95.1
0.80
1306
9521
(3002619) Bacteria identified in Specimen by Culture
17
179
0.72
0.65
1.3
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
17
179
0.72
0.65
1.4
1.4
nmol/l
0.1
0.1
—
10
129
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
17
179
0.72
0.65
1.1
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
10
117
0.64
0.64
1.2
1.1
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
9236
70113
0.98
0.63
22.6
23.4
umol/l
87.3
88.0
0.85
9230
70065
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
30
175
1.29
0.63
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
59
528
0.84
0.63
1.7
1.7
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
66
584
0.85
0.62
1.0
1.1
—
19.8
—
0
11
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
15
160
0.71
0.62
1.3
1.1
pmol/l
222.2
255.8
—
10
105
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
489
3899
0.94
0.62
1.9
1.8
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
15
0.00
0.61
0.0
7.1
—
42.2
—
0
15
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
15
0.00
0.61
0.0
13.9
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
15
0.00
0.61
0.0
1.1
—
0.0
—
0
10
(36303858) Crystals [Presence] in Urine
0
15
0.00
0.61
0.0
1.2
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
15
0.00
0.61
0.0
7.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.61
0.0
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
109
726
1.13
0.60
1.3
1.3
titre
51.4
57.4
—
7
62
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
17
0.00
0.60
0.0
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
157
1307
0.90
0.60
1.4
1.4
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
16
167
0.72
0.59
1.1
1.1
umol/24h
0.6
0.7
—
9
69
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
0
18
0.00
0.59
0.0
3.6
—
17.2
—
0
13
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
18
0.00
0.59
0.0
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
15
158
0.72
0.59
1.1
1.1
—
9.3
—
0
15
(3000012) Reticulocyte production index
74
644
0.87
0.58
1.7
1.5
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
55
490
0.85
0.58
1.7
2.0
umol/l
20.3
25.1
—
9
53
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
954
7456
0.96
0.55
1.6
1.9
g/l
0.2
0.2
0.07
806
6793
(3037756) Immunofixation for Serum or Plasma
291
2348
0.93
0.55
1.3
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
607
4366
1.05
0.55
1.8
1.8
ug/l
3.2
2.3
0.50
452
3720
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
6
28
1.62
0.55
1.0
1.1
—
4.0
—
0
10
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
24
139
1.30
0.55
1.1
1.3
ug/l
75.8
103.6
0.55
16
84
(3002032) Base excess in Venous blood by calculation
1291
9442
1.03
0.53
2.6
3.5
mmol/l
2.0
2.0
0.31
1045
7571
(3020961) Endomysium IgA Ab [Titer] in Serum
268
2159
0.93
0.50
1.1
1.1
titre
465.6
221.6
—
8
38
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
14
144
0.73
0.49
1.5
1.4
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
42
375
0.84
0.48
1.1
2.5
mg/l
65.5
67.7
0.09
24
242
(3006184) Hemoglobin [Mass/volume] in Capillary blood
291
2331
0.94
0.47
2.2
2.3
g/l
127.0
124.6
1.01
240
1733
(3003181) Sodium [Moles/volume] in Urine
268
1894
1.07
0.47
1.3
1.3
mmol/l
62.1
60.7
0.27
215
1518
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
117
0.71
0.47
1.0
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
699
5070
1.04
0.47
3.5
2.9
e6/l
0.5
0.3
1.01
684
4982
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1073
8334
0.97
0.47
2.1
2.5
umol/l
10.8
9.9
0.44
853
7207
(3029634) Reagin Ab [Titer] in Serum by VDRL
53
463
0.86
0.47
1.4
1.4
—
3.8
—
0
5
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
28
170
1.24
0.47
1.1
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
7579
57555
0.98
0.47
5.4
7.4
u/l
83.2
83.4
0.07
6772
53568
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
66
567
0.88
0.46
1.1
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
13
70
1.40
0.46
1.1
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
63
0.60
0.46
1.2
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1290
9463
1.03
0.46
2.6
3.5
kpa
5.9
5.8
1.21
1225
9143
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
7
37
1.43
0.46
1.0
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
10
107
0.70
0.45
1.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
84
708
0.89
0.45
1.5
1.4
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
17
97
1.32
0.44
3.4
5.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
37
331
0.84
0.44
6.0
5.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
13
132
0.74
0.43
1.8
1.6
ug/l
9.6
9.6
0.00
13
132
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
13
132
0.74
0.43
1.0
1.3
%
113.5
113.6
—
8
115
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
132
0.74
0.43
1.0
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
8
41
1.47
0.43
1.0
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
2028
14984
1.02
0.43
3.0
3.1
e6/l
1.7
1.5
0.45
1151
8888
(3027945) Reticulocytes/100 erythrocytes in Blood
1677
12365
1.03
0.42
2.1
2.2
%
1.7
1.8
0.48
1297
10690
(3025941) Bacteria identified in Stool by Culture
498
3598
1.04
0.42
1.3
1.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
21
125
1.27
0.42
6.5
8.8
%
13.6
13.8
0.52
21
125
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
12
0.00
0.42
0.0
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
12
0.00
0.42
0.0
1.0
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
13
0.00
0.41
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
13
0.00
0.41
0.0
1.2
—
8.3
—
0
13
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
13
0.00
0.41
0.0
4.6
—
365.2
—
0
13
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
44
385
0.86
0.41
1.3
1.3
ug/l
575.7
263.5
0.26
26
207
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
44
1.37
0.41
1.0
1.0
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
23
214
0.81
0.41
1.0
1.2
mmol/l
1.4
1.4
0.03
13
128
(3051611) Lipemic interference index of Serum or Plasma
122
1002
0.92
0.41
3.2
3.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
21
197
0.80
0.40
1.3
1.3
u/l
2.9
1229.2
—
6
74
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.40
0.0
1.1
—
36.1
—
0
14
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
14
0.00
0.40
0.0
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
357
2824
0.95
0.40
3.3
3.7
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
77
0.68
0.40
1.1
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
7
80
0.66
0.40
1.3
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
20
188
0.80
0.39
1.1
1.1
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
17
163
0.79
0.39
1.1
1.3
%
80.1
75.1
0.25
11
138
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
32
286
0.84
0.39
1.1
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
6885
52262
0.99
0.37
24.9
23.9
%
14.1
14.1
0.28
6638
50898
(3012501) Base excess in Blood by calculation
311
2232
1.05
0.36
3.8
4.4
mmol/l
2.7
2.8
0.49
216
1536
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1866
13810
1.02
0.36
1.6
1.9
s
29.7
30.3
2.53
1783
13380
(3025315) Body weight
5
60
0.63
0.36
7.0
5.4
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
311
2234
1.05
0.36
3.8
4.5
kpa
5.0
5.0
0.01
299
2161
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
670
4892
1.03
0.35
3.3
4.3
%
46.0
45.9
0.05
660
4834
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
50
427
0.88
0.35
4.7
4.7
u/ml
86.4
141.7
—
10
124
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
20
185
0.81
0.35
1.4
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
16
152
0.79
0.35
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
38
247
1.16
0.35
1.1
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
67
561
0.90
0.35
2.0
2.4
mmol/l
7.2
7.3
0.18
49
380
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
37
241
1.16
0.33
1.6
1.8
nmol/l
11.2
14.0
1.75
32
217
(3044007) Cell count panel - Peritoneal fluid
24
216
0.84
0.33
2.0
1.8
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
49
416
0.89
0.33
1.8
2.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
50
334
1.13
0.33
1.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
55
462
0.90
0.31
3.9
3.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
15
141
0.80
0.31
1.3
1.3
mu/l
42.6
77.4
—
10
95
(3024869) Neuronal Ab [Presence] in Serum
16
149
0.81
0.31
1.1
1.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
23
206
0.84
0.31
1.4
1.4
g/l
13.0
15.2
0.53
16
163
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
13
124
0.79
0.30
1.2
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
15
140
0.81
0.30
1.1
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
7
42
1.26
0.29
1.0
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
3262
24318
1.01
0.29
3.5
3.5
e6/l
0.6
0.5
1.13
2556
18842
(3027923) C peptide [Moles/volume] in Serum or Plasma
41
349
0.89
0.29
1.1
1.3
nmol/l
1.1
1.2
0.07
29
260
(3027315) Oxygen [Partial pressure] in Blood
310
2243
1.04
0.29
3.8
4.5
kpa
7.8
8.2
6.53
297
2170
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
21
188
0.84
0.28
1.1
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
24
212
0.85
0.28
2.6
2.2
—
31.3
—
0
8
(40761536) Microorganisms panel - Urine sediment
840
6478
0.98
0.28
4.8
4.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
924
6813
1.02
0.28
2.2
2.3
u/l
32.0
37.2
2.53
747
5751
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
90
0.75
0.27
1.0
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
799
5882
1.03
0.27
1.7
2.0
nmol/l
409.1
386.3
2.43
663
5274
(3033705) Calcium.ionized [Moles/volume] in Venous blood
210
1659
0.95
0.27
2.6
2.6
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
19
170
0.84
0.26
2.1
2.0
ug/l
2.8
3.3
—
10
69
(3002331) Protein [Mass/volume] in Peritoneal fluid
20
178
0.85
0.26
1.3
1.3
g/l
26.5
60.4
0.56
13
146
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
59
486
0.91
0.25
1.2
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
59
486
0.91
0.25
1.2
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
129
917
1.06
0.25
2.7
2.9
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
72
1.26
0.24
1.2
1.1
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
35
296
0.89
0.24
1.2
1.4
%
20.2
21.2
0.08
26
240
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
19
121
1.18
0.24
1.3
1.1
miu/ml
1565.7
1773.4
0.29
19
121
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
958
7356
0.98
0.23
2.7
3.4
ng/l
90.9
99.5
2.09
735
6027
(3026389) Candida sp identified in Specimen by Organism specific culture
126
1001
0.95
0.22
1.3
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.22
0.0
1.3
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
8
0.00
0.22
0.0
3.6
—
—
—
0
0
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
8
0.00
0.22
0.0
1.0
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
9
0.00
0.21
0.0
1.6
—
1.9
—
0
9
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
9
0.00
0.21
0.0
1.9
—
2.3
—
0
9
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
9
0.00
0.21
0.0
1.1
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
577
4250
1.02
0.21
3.9
4.4
%
1.7
1.5
1.51
544
4006
(3029396) Erythrocyte agglutination [Presence] in Blood
5
32
1.18
0.21
1.6
1.3
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
19
166
0.86
0.21
1.1
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
2504
18691
1.01
0.20
4.5
4.4
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
27
229
0.89
0.20
3.1
2.5
mmol/l
7.1
7.4
0.35
15
155
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
11
0.00
0.20
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
11
0.00
0.20
0.0
1.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
11
0.00
0.20
0.0
1.1
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
11
0.00
0.20
0.0
1.0
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
11
0.00
0.20
0.0
3.0
—
—
—
0
0
(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid
0
11
0.00
0.20
0.0
8.5
—
55.6
—
0
5
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
11
0.00
0.20
0.0
1.1
—
0.2
—
0
11
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
31
209
1.12
0.20
1.3
1.5
pmol/l
18.1
16.7
0.70
21
159
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
17
149
0.86
0.19
1.1
1.2
u/l
36.7
288.8
—
9
98
(3024928) Oxygen saturation in Venous blood
249
1815
1.03
0.19
1.6
2.5
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
6
39
1.16
0.19
1.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
13
116
0.84
0.18
1.5
1.6
umol/l
45.8
47.6
0.09
13
116
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
124
892
1.05
0.18
1.4
1.6
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
10
61
1.24
0.18
1.0
1.1
u/field
0.8
1.1
—
5
38
(3034092) Cytoplasmic Ig cells/100 cells in Blood
11
68
1.22
0.18
10.9
14.8
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
46
1.15
0.17
1.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
53
0.71
0.17
4.2
4.0
—
—
—
0
0
(3019977) pH of Arterial blood
88
629
1.05
0.17
2.1
2.3
ph
7.4
7.4
0.92
19
240
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
51
1.18
0.17
1.1
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
29
241
0.91
0.16
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
124
974
0.96
0.16
1.3
1.5
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
27
184
1.11
0.15
1.3
1.4
%
20.8
21.8
0.05
16
141
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
27
184
1.11
0.15
1.1
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
40
325
0.93
0.15
2.3
2.9
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
623
4620
1.02
0.15
2.1
2.5
%
0.7
0.7
1.53
602
4443
(3027273) Bicarbonate [Moles/volume] in Venous blood
696
5324
0.98
0.14
2.8
3.4
mmol/l
25.4
25.1
1.39
663
5175
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
10
63
1.20
0.14
1.2
1.2
u/l
11.5
12.7
—
10
63
(3016330) Potassium [Moles/time] in 24 hour Urine
8
74
0.81
0.14
1.6
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
74
0.81
0.14
1.6
1.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
10
89
0.85
0.14
1.2
1.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
800
6109
0.99
0.14
2.6
3.2
g/l
127.1
125.2
1.93
780
5959
(3023383) Lactate [Moles/volume] in Pleural fluid
49
393
0.94
0.13
1.2
1.3
mmol/l
4.3
3.4
0.85
39
358
(40767503) Oxygen content in Capillary blood by calculation
279
2152
0.98
0.13
2.4
2.6
%
16.1
15.5
1.38
115
1157
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
31
253
0.92
0.13
1.2
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
567
4209
1.02
0.13
3.8
4.4
%
0.9
0.9
4.26
535
3960
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
146
1135
0.97
0.12
4.9
5.8
mg/l
12.9
12.8
0.16
122
1015
(3002621) Streptococcal DNAse B [Units/volume] in Serum
10
64
1.18
0.12
1.0
1.1
—
—
—
0
0
(4212803)
15
100
1.13
0.12
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
35
246
1.07
0.11
1.0
1.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
40
321
0.94
0.11
3.6
6.3
mmol/l
24.5
24.7
0.12
33
291
(3032773) Endomysium IgG Ab [Titer] in Serum
59
423
1.05
0.11
1.1
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
34
1.11
0.10
1.4
1.7
umol/l
22.0
15.9
—
5
34
(3033799) Differential panel - Peritoneal fluid
31
249
0.94
0.09
1.6
1.6
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
36
1.05
0.09
1.0
1.0
—
—
—
0
0
(44806071)
6
41
1.10
0.09
1.3
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
41
1.10
0.09
1.0
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
109
0.90
0.08
1.3
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
6
44
1.03
0.08
1.2
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
48
0.78
0.08
1.0
1.2
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
39
280
1.05
0.07
1.3
1.4
%
77.0
62.5
3.19
27
241
(3035933) Granulocytes/100 leukocytes in Blood
9
63
1.08
0.07
1.6
1.3
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
11
74
1.12
0.07
1.3
1.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
9
66
1.03
0.07
1.4
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
9
66
1.03
0.07
1.8
1.8
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
24
170
1.06
0.06
1.1
1.2
nmol/l
118.8
135.9
0.23
16
125
(3051651) Icteric interference index of Serum or Plasma
72
527
1.03
0.06
3.2
3.5
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
10
84
0.90
0.06
1.7
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
154
1181
0.98
0.06
1.3
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
48
349
1.04
0.06
1.2
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
68
527
0.97
0.06
2.1
1.8
mu/l
291.2
327.4
0.37
61
484
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
103
793
0.98
0.06
1.3
1.5
—
—
—
0
0
(3001729) Color of Synovial fluid
12
99
0.91
0.05
1.8
1.7
—
—
—
0
0
(44790047)
99
762
0.98
0.05
1.4
1.3
—
—
—
0
0
(44790048)
99
762
0.98
0.05
1.4
1.3
—
—
—
0
0
(44790049)
99
762
0.98
0.05
1.4
1.3
—
—
—
0
0
(44806118)
99
761
0.98
0.05
1.4
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
59
457
0.97
0.05
1.4
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1246
9428
1.00
0.04
1.7
1.9
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
21
150
1.06
0.04
1.4
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
3269
24608
1.00
0.02
2.2
2.5
u/l
58.7
60.1
0.59
2919
22496
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
448
3362
1.00
0.02
2.7
3.0
pmol/l
4.3
4.3
0.02
363
2848
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
28
206
1.02
0.01
1.2
1.3
%
22.9
28.4
0.39
19
138
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
14
104
1.01
0.00
1.2
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
13
98
1.00
0.00
1.2
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
60
448
1.01
0.00
1.1
1.2
miu/ml
228.7
179.6
—
8
79
(3003740) Influenza virus B Ag [Presence] in Specimen
32
241
1.00
0.00
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
78
591
0.99
0.00
1.3
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
32
237
1.02
0.00
1.0
1.1
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
20
154
0.98
0.00
1.1
1.2
mmol/l
0.9
1.9
—
10
90
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
16
117
1.03
0.00
1.4
1.8
ug/l
1.4
1.3
0.06
16
108
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
13
100
0.98
0.00
1.3
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
42
0.90
0.00
1.2
1.1
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
5
42
0.90
0.00
1.2
1.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
7
54
0.98
0.00
1.0
1.1
—
—
—
0
0
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
6
45
1.00
0.00
1.2
1.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
9
70
0.97
0.00
1.0
1.1
umol/24h
1.8
1.7
—
9
70
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
1.8
—
0
7
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
3.4
—
3.1
—
0
5
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
9
69
0.98
0.00
1.0
1.1
—
—
—
0
0
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
5.6
—
14.0
—
0
5
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
75
0.90
0.00
1.0
1.1
—
—
—
0
0
(3028917) Waxy casts [#/area] in Urine by Computer assisted method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009220) Epithelial cells.squamous [#/volume] in Urine sediment
0
5
0.00
0.00
0.0
1.2
—
3.4
—
0
5
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030940) RBC casts [#/area] in Urine by Computer assisted method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_ALZHEIMER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_ALZHEIMER | 2.419 [2.2, 2.66] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 74328 out of 110920 females with G6_ALZHEIMER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_ALZHEIMER | 2.756 [2.43, 3.13] | < 0.001 |
| Birth year | 0.984 [0.98, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 42782 out of 61190 males with G6_ALZHEIMER died.
Mortality risk
Mortality risk for people of age
years, who have G6_ALZHEIMER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.184% | 0.451% |
| 5 | 1.156% | 2.751% |
| 10 | 2.546% | 6.244% |
| 15 | 4.559% | 11.313% |
| 20 | 8.12% | 18.563% |
Relationships between endpoints
↥Index endpoint: G6_ALZHEIMER – Alzheimer disease
GWS hits: 25
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data